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SILENCE IS GOLDEN . . . EXCEPT IN HEALTH CARE
PHILANTHROPY
Stacey A. Tovino *
INTRODUCTION
Imagine a forty-year-old woman who has been diagnosed with
stage IV colorectal cancer and who has less than a ten percent
chance of living five years from the date of her diagnosis. The
woman’s physician, who specializes in oncology and practices at a
hospital affiliated with a major academic medical center, recommends a combination of surgery, chemotherapy, and radiation to
treat the woman’s cancer. This article addresses the permissible
scope of uses and disclosures of the woman’s individually identifiable health information that may be made by the hospital and the
physician for the purpose of attempting to raise funds for the
hospital’s own benefit.
If, five years after her diagnosis, the woman is still alive and
has no evidence of disease, should the hospital be permitted to select the woman, based on her treatment in the oncology department, her excellent outcome, and her presumed gratitude, to receive a telephone call or a letter at her home requesting a
monetary donation that would be used to improve the infrastruc-

* Lincy Professor of Law, William S. Boyd School of Law, University of Nevada, Las
Vegas. Ph.D., University of Texas Medical Branch; J.D., University of Houston Law Center; B.A., Tulane University. I thank Nancy Rapoport, Interim Dean, and Daniel Hamilton, Dean, William S. Boyd School of Law, for their financial support of this research project. I also thank William J. Winslade (James Wade Rockwell Professor of Medicine,
University of Texas Medical Branch) for his comments on an earlier presentation of this
article, and Jeanne Price (Director, Wiener-Rogers Law Library), Chad Schatzle (Student
Services Librarian, Wiener-Rogers Law Library), Jennifer Gross (Reference and Collection
Management Librarian, Wiener-Rogers Law Library), Bryn Esplin (3L and President,
Health Law Society, Boyd School of Law), and Danny Gobaud (3L, Boyd School of Law) for
their outstanding assistance in locating many of the sources referenced in this article. I
further thank the participants of the 66th Annual Meeting of the Southeastern Association of Law Schools in Palm Beach, Florida, for their helpful comments and suggestions on
earlier presentations and versions of this article.
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ture of, and the medical technology and human resources available through, the hospital’s oncology department? In addition,
when the woman visits the hospital for follow-up cancer screenings, should her physician be permitted to initiate private conversations with her regarding the hospital’s philanthropic needs? On
the other hand, if the woman’s condition deteriorates or she dies
within five years of her diagnosis, should the hospital be able to
use the woman’s poor health or the fact of her death to screen her
or her family members out from the receipt of philanthropyrelated communications? Or, due to legal and ethical concerns associated with patient confidentiality, should the hospital and
physician be prohibited from engaging in any of the fundraising
activities described in this paragraph?
On January 25, 2013, the federal Department of Health and
Human Services (“HHS”) issued final regulations (“Final Regulations”)1 modifying the privacy rule (“Privacy Rule”)2 that imple3
ments section 264 of the administrative simplification provisions
within the Health Insurance Portability and Accountability Act of
1996 (“HIPAA”).4 These Final Regulations changed the answers
to some of the questions raised above. More recently, on September 16, 2013, HHS issued a model notice of privacy practices
(“Model Notice”) that would provide patients with little information regarding how their health care providers use and disclose patient information for fundraising purposes.5 This article is
the first law review article to critique and propose corrections to
provisions within the Final Regulations that expand the permissible scope of uses and disclosures of protected health information
6
7
(“PHI”) for fundraising purposes as well as related provisions

1. Modifications to the HIPAA Privacy, Security, Enforcement, and Breach Notification Rules under the Health Information Technology for Economic and Clinical Health Act
and the Genetic Information Nondiscrimination Act; Other Modifications to the HIPAA
Rules, 78 Fed. Reg. 5566, 5700 (Jan. 25, 2013) (to be codified at 45 C.F.R. pts. 160, 164).
2. Privacy of Individually Identifiable Health Information, 45 C.F.R. §§ 164.500–.534
(2013).
3. The Health Insurance Portability and Accountability Act of 1996, Pub. L. No. 104191, § 264, 110 Stat. 1936, 2033 (1996).
4. Id. §§ 261–70.
5. U.S. DEP’T HEALTH & HUMAN SERVS., NOTICE OF PRIVACY PRACTICES 3–5 (2013)
[hereinafter MODEL NOTICE].
6. OTHER MODIFICATIONS TO THE HIPPA RULES, 78 Fed. Reg. at 5689 (defining PHI
with reference to individually identifiable health information with certain exceptions).
7. Technical Corrections to the HIPAA Privacy, Security, and Enforcement Rules, 78
Fed. Reg. 32,466, 32,466 (June 7, 2013) (to be codified at 45 C.F.R. pts. 160, 164).
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within the Model Notice that fail to alert patients to these expanded information uses and disclosures.8
This article proceeds as follows: Part I reviews the history of
the Privacy Rule. Part II examines HHS’s regulation of the use
and disclosure of PHI for fundraising with a focus on HHS’s progressively weakened confidentiality protections. That is, in a proposed rule issued in 1999, HHS would have required prior written
authorization from a patient before the patient’s health care providers could use or disclose the patient’s PHI for fundraising purposes. In a final rule issued in 2000, HHS changed tack, allowing
health care providers to use and disclose some limited demographic information about the patient as well as the patient’s
dates of health care for fundraising purposes without prior written authorization. Other information uses and disclosures still
required prior written authorization from the patient. In early
2013, HHS significantly expanded the classes of PHI that health
care providers may use and disclose for fundraising without prior
patient authorization and, in fall 2013, HHS released its Model
Notice, which does not alert patients to these additional information uses and disclosures. Part II of this article carefully
charts the diminution of HHS’s confidentiality protections in the
context of fundraising over the last fourteen years with a special
focus on the content of public commentary provided during the
notice-and-comment rulemaking process as well as HHS’s response to that commentary. Part II thus focuses on the development and current status of the law of grateful patient fundraising
and other activities designed to increase philanthropic donations
to hospitals and other health care institutions.
Part III of this article examines the growing business of health
care philanthropy. Part III explains why health care institutions
rely so heavily on philanthropic donations, including because of
the expense of medical equipment, inadequate Medicare and
Medicaid reimbursement, high uncompensated health care costs,
and rising health care compliance costs associated with health
care reform. Part III chronicles the ways in which health care institutions attempt to increase revenue through health care philanthropy. Part III focuses in particular on one type of health care
philanthropy known as grateful patient fundraising and details

8.

See infra Part IV.
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the ways in which hospitals and physicians identify and solicit
grateful patients.
Part IV of this article examines whether the Final Regulations
properly balance an individual’s interest in maintaining health
information confidentiality with the interest of health care providers in obtaining philanthropic donations. Concluding that the
Final Regulations do not properly balance such interests, Part IV
argues that prior written authorization should be sought and obtained before any information other than demographic information and dates relating to the provision of health care (collectively, “demographic information”) is used or disclosed for
fundraising purposes for four reasons. First, patients likely do not
expect that their PHI is being used and disclosed for fundraising
purposes in exchange for their request for and receipt of health
care and the Model Notice does nothing to improve these patient
expectations. Second, fundraising is neither a core function of
covered entities nor necessary to support a core function of covered entities. Third, a fundraiser who receives and uses nondemographic information to create a targeted fundraising communication or a third party who reads a targeted fundraising
communication could easily determine the patient’s general
health condition or the health care services requested or received
by the patient. Fourth, a close examination of the comments received by HHS in response to the proposed rule that preceded the
Final Regulations does not reveal a shift in public attitudes regarding the appropriate balance of health information confidentiality and health care philanthropy. Rather, the comments indicate that covered entities would still like to gather, use, and
disclose as much information as possible about patients for fundraising purposes and that patients’ rights advocates and privacy
coalitions still prefer to prioritize patient confidentiality. The fact
that covered entities would still like to gather, use, and disclose
an expanded class of PHI for fundraising does not mean that philanthropy should, on a normative level, outweigh basic patients’
rights. Rather, this article proposes that health information confidentiality and health care philanthropy be balanced through a
more express notification of fundraising and prior authorization
requirement.
Part V of this article proposes corrections to provisions within
the Final Regulations and the Model Notice governing the use
and disclosure of PHI for fundraising activities. That is, Part V
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proposes a prohibition on health care providers using or disclosing PHI, other than demographic information, for fundraising
purposes without prior written notification to and authorization
from the patient. Part V offers sample fundraising notification
and authorization language that health care providers may incorporate into their informed consent conversations, notices of
privacy practices, and authorization forms. Because the Privacy
Rule is necessarily limited to the topic of health information confidentiality, Part V also incorporates by reference a complementary set of ethical guidelines proposed in a companion article.9
These guidelines address and resolve additional ethical issues
raised by physician involvement in grateful patient fundraising.
I. THE PRIVACY RULE: A BRIEF HISTORY
As signed into law by President Clinton on August 21, 1996,
HIPAA had several purposes, including improving portability and
continuity of health insurance coverage in individual and group
markets, combating health care fraud and abuse, promoting the
use of medical savings accounts, improving access to long-term
care services and insurance coverage, and simplifying the administration of health insurance.10 The administrative simplification
provisions, codified at Subtitle F of Title II of HIPAA, directed
11
HHS to issue regulations protecting the privacy of individually

9. See Stacey A. Tovino, Giving Thanks: The Ethics of Grateful Patient Fundraising,
103 KY. L.J. (forthcoming 2015) [hereinafter Tovino, Giving Thanks].
10. The Health Insurance Portability and Accountability Act of 1996, Pub. L. No. 104191, 110 Stat. 1936 (1996).
11. Id. § 264(c), 110 Stat. at 2033. Elsewhere, I defined and distinguished the concepts
of privacy and confidentiality in the context of advances in functional magnetic resonance
imaging. Stacey A. Tovino, Functional Neuroimaging Information: A Case for Neuro Exceptionalism?, 34 FLA. ST. U. L. REV. 415, 441–42 (2007) [hereinafter Tovino, Functional
Neuroimaging Information]. This article uses these same basic definitions and distinctions. That is, in the health care context, “privacy” includes a patient’s interest in avoiding
the unwanted collection by a third party of health or other information about the patient.
Id. at 442. On the other hand, “confidentiality” refers to the obligation of a health industry
participant to prevent the unauthorized or otherwise inappropriate use or disclosure of
voluntarily given and appropriately gathered health and other information relating to a
patient. Id. The terms “privacy” and “confidentiality” are frequently confused. Indeed, the
Privacy Rule is actually a health information confidentiality rule because it sets limits on
how health care providers and other covered entities can use and disclose appropriately
gathered PHI. Id. at 449. However, I do use the term “Privacy Rule” in this article because
that is the name given by HHS and used by the public for the rule. See, e.g., HIPAA and
the Privacy Rule, PARTNERS HEALTH CARE, https://healthcare.partners.org/phsirb/hrchi
paa.htm (last visited Apr. 14. 2014); The Privacy Rule, U.S. DEP’T HEALTH & HUMAN
SERVS., http://www.hhs.gov/ocr/privacy/hipaa/administrative/privacyrule/index.html (last
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identifiable health information if Congress failed to enact comprehensive privacy legislation within three years of HIPAA’s enactment.12 When Congress failed to enact privacy legislation by its
deadline, HHS incurred the duty to adopt privacy regulations.13
The original HIPAA statute clarified, however, that any privacy
regulations adopted by HHS must be made applicable only to
three classes of individuals and institutions: (1) health plans; (2)
health care clearinghouses; and (3) health care providers who
transmit health information in electronic form in connection with
certain standard transactions (each, a “covered entity”; collectively, “covered entities”).14
HHS responded. On November 3, 1999,15 and December 28,
2000, HHS issued a proposed and final Privacy Rule regulating
16
covered entities’ uses and disclosures of, and requests for, PHI.
17
On March 27, 2002, and August 14, 2002, HHS issued proposed
and final modifications to the Privacy Rule.18 With the exception
19
of technical corrections and conforming amendments, these
rules as reconciled remained largely unchanged between 2002
and 2009.

visited Apr. 14, 2014).
12. § 264(c), 110 Stat. at 2033 (“If legislation governing standards with respect to the
privacy of individually identifiable health information . . . is not enacted by the date that
is 36 months after the date of the enactment of this Act, the Secretary of Health and Human Services shall promulgate final regulations containing such standards . . . .”).
13. See id.
14. Id. § 1172(a), 110 Stat. at 2023. See generally Standards for Privacy of Individually Identifiable Health Information, 64 Fed. Reg. 59,918, 59,924 (proposed Nov. 3, 1999) (to
be codified at 45 C.F.R. pts. 160–64) (explaining that HHS did not directly regulate any
entity that was not a covered entity because it did not have the statutory authority to do
so).
15. Standards for Privacy of Individually Identifiable Health Information, 64 Fed.
Reg. at 59,918.
16. Standards for Privacy of Individually Identifiable Health Information, 65 Fed.
Reg. 82,462 (Dec. 28, 2000) (to be codified at 45 C.F.R. pts. 160, 164).
17. Standards for Privacy of Individually Identifiable Health Information, 67 Fed.
Reg. 14,776 (proposed Mar. 27, 2002) (to be codified at 45 C.F.R. pts. 160, 164).
18. Standards for Privacy of Individually Identifiable Health Information, 67 Fed.
Reg. 53,182 (Aug. 14, 2002) (to be codified at 45 C.F.R. pts. 160, 164).
19. See, e.g., Standards for Privacy of Individually Identifiable Health Information,
Final Rule; Correction of Effective and Compliance Dates, 66 Fed. Reg. 12,434 (Feb. 26,
2001) (to be codified at 45 C.F.R. pts. 160, 164); Technical Corrections to the Standards for
Privacy of Individually Identifiable Health Information Published December 28, 2000, 65
Fed. Reg. 82,944 (Dec. 29, 2000) (to be codified at 45 C.F.R. pts. 160, 164).

TOVINO 484 (DO NOT DELETE)

2014]

4/18/2014 9:12 AM

HEALTH CARE PHILANTHROPY

1163

The nature and scope of the legal duties of confidentiality that
applied to covered entities and their business associates (“BAs”)20
changed significantly over four years ago. On February 17, 2009,
President Obama signed the American Recovery and Reinvestment Act (“ARRA”) into law.21 Division A, Title XIII of ARRA, better known as the Health Information Technology for Economic
and Clinical Health Act (“HITECH”), contained certain provisions
that required HHS to modify some of the information use and disclosure requirements and definitions set forth in the Privacy Rule
as well as the amount of civil penalties that may be imposed on
covered entities and BAs who violate the Privacy Rule.22
Since ARRA’s enactment, HHS has been busy issuing proposed
rules, interim final rules, final rules, and technical corrections
that implement HITECH’s required changes to the Privacy Rule.
On August 24, 2009, HHS released an interim final rule implementing HITECH’s new breach notification requirements.23 On
October 30, 2009, HHS released an interim final rule implementing HITECH’s strengthened enforcement provisions, including
strengthened civil monetary penalties that the federal Office for
Civil Rights may, for the first time since the enactment of the
HIPAA statute, impose directly on BAs who fail to maintain the

20. Business associates are defined to include individuals and institutions who: (1) on
behalf of a covered entity, but other than in the capacity of a member of the workforce of a
covered entity, create, receive, maintain, or transmit PHI for a function or activity regulated by the HIPAA Privacy Rule, and (2) provide, other than in the capacity of a member
of the workforce of such covered entity, legal, actuarial, accounting, consulting, data aggregation, management, administrative, accreditation, or financial services to or for the
covered entity. See Modifications to the HIPAA Privacy, Security, Enforcement, and
Breach Notification Rules under the Health Information Technology for Economic and
Clinical Health Act and the Genetic Information Nondiscrimination Act, 78 Fed. Reg.
5566, 5688 (Jan. 25, 2013) (to be codified at 45 C.F.R. pts. 160, 164).
21. American Recovery and Reinvestment Act of 2009, Pub. L. No. 111-5, 123 Stat.
115 (2009).
22. Health Information Technology for Economic and Clinical Health Act, Pub. L. No.
111-5, § 3001, 123 Stat. 115, 226–32 (2009). Elsewhere, I critiqued HITECH’s imposition
of confidentiality requirements directly on BAs and I proposed statutory and regulatory
changes to HITECH and the HIPAA Privacy Rule, respectively, that would except a class
of BAs, including outside counsel, from the confidentiality obligations imposed on other
BAs. See Stacey A. Tovino, Gone Too Far: Federal Regulation of Health Care Attorneys, 91
OR. L. REV. 813 (2013) [hereinafter Tovino, Gone Too Far]. This article builds on my earlier work by further critiquing the Final Regulations in an additional context; that is, in the
context of hospitals that wish to use and disclose PHI to raise funds for their own benefit.
23. Breach Notification for Unsecured Protected Health Information, 74 Fed. Reg.
42,740, 42,740 (Aug. 24, 2009) (to be codified at 45 C.F.R. pts. 160, 164); Macon Phillips,
Signed, Sealed, Delivered: ARRA, WHITE HOUSE BLOG (Feb. 17, 2009, 4:25 PM), http://
www.whitehouse.gov/blog/09/02/17/signed-sealed-delivered-ARRA.
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confidentiality of PHI.24 On July 14, 2010, HHS released a proposed rule that would modify the HIPAA Privacy, Security,
Breach Notification, and Enforcement Rules in accordance with
HITECH.25 On May 31, 2011, HHS released a proposed rule that
would modify the HIPAA Privacy Rule’s accounting of disclosures
requirement.26 On September 14, 2011, HHS released a proposed
rule that would modify the Privacy Rule to provide individuals
with the right to receive their laboratory test reports directly
from their testing laboratories.27 On January 25, 2013, HHS released the Final Regulations, which modify the HIPAA Privacy,
Security, Breach Notification, and Enforcement Rules in accord28
ance with HITECH. On June 7, 2013, HHS released technical
29
corrections to the Final Regulations. Finally, on September 16,
2013, HHS released the Model Notice designed to assist covered
entities in complying with the Final Regulations.30 This article
critiques and proposes further corrections to the fundraising provisions that were set forth in the January 25, 2013 rulemaking,
and technically corrected on June 7, 2013,31 as well as related
fundraising provisions within the Model Notice.
The critiques and proposals set forth in this article are illustrative rather than exhaustive. I disagree with many of the changes
set forth in the Final Regulations and this article is but one installment in a series of articles criticizing the Final Regulations.
Elsewhere, I critiqued HITECH’s imposition of confidentiality re-

24. HIPAA Administrative Simplification: Enforcement, 74 Fed. Reg. 56,123, 56,123
(Oct. 30, 2009) (to be codified at 45 C.F.R. pts. 160, 164).
25. Modifications to the HIPAA Privacy, Security, and Enforcement Rules Under the
Health Information Technology for Economic and Clinical Health Act, 75 Fed. Reg. 40,868
(proposed July 14, 2010) (to be codified at 45 C.F.R. pts. 160, 164).
26. HIPPA Privacy Rule Accounting of Disclosures Under the Health Information
Technology for Economic and Clinical Health Act, 76 Fed. Reg. 31,426, 31,426 (proposed
May 31, 2011) (to be codified at 45 C.F.R. pt. 164).
27. CLIA Program and HIPAA Privacy Rule; Patients’ Access to Test Reports, 76 Fed.
Reg. 56,712, 56,712 (proposed Sept. 14, 2011) (to be codified at 45 C.F.R. pt. 164).
28. Modifications to the HIPAA Privacy, Security, Enforcement, and Breach Notification Rules under the Health Information Technology for Economic and Clinical Health Act
and the Genetic Information Nondiscrimination Act, 78 Fed. Reg. 5566, 5566 (Jan. 25,
2013) (to be codified at 45 C.F.R. pts. 160, 164).
29. Technical Corrections to the HIPAA Privacy, Security, and Enforcement Rules, 78
Fed. Reg. 32,466, 32,466 (June 7, 2013) (to be codified at 45 C.F.R. pts. 160, 164).
30. MODEL NOTICE, supra note 5.
31. Modifications to the HIPAA Privacy, Security, Enforcement, and Breach Notification Rules under the Health Information Technology for Economic and Clinical Health Act
and the Genetic Information Nondiscrimination Act, 78 Fed. Reg. at 5566; Technical Corrections to the HIPAA Privacy, Security, and Enforcement Rules, 78 Fed. Reg. at 32,466.
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quirements directly on BAs and proposed a correction that would
except certain classes of BAs that are already regulated with respect to their use and disclosure of confidential client information, including state-licensed attorneys who are subject to
state bar disciplinary action for the misuse of confidential client
information.32 In addition, on May 31, 2011, HHS released a proposed rule that would modify the Privacy Rule’s accounting of
disclosures requirement to include an access report requirement.33
If HHS adopts the access report requirement in final regulations,
I will make an administrative law critique of those final regulations as well. This article is well situated between my completed
article and my anticipated article as it has a specific and detailed
goal; that is, to properly balance a patient’s interest in maintaining the confidentiality of his or her health information with the
interest of a health care provider in using and disclosing the patient’s PHI to raise funds for the provider’s own benefit.
Before proceeding towards this goal, a brief summary of the
Privacy Rule’s theory and approach to health information confidentiality is necessary. The Privacy Rule has as its goal the balancing of the interest of individuals in maintaining the confidentiality of their health information and the interest of society in
obtaining, using, and disclosing health information to carry out a
34
variety of public and private activities. To that end, the Privacy
Rule regulates covered entities’ and BAs’ uses of, disclosures of,
35
and requests for individually identifiable health information to

32. See Tovino, Gone Too Far, supra note 22, at 814–67.
33. HIPAA Privacy Rule Accounting of Disclosures Under the Health Information
Technology for Economic and Clinical Health Act, 76 Fed. Reg. 31,426, 31,429 (proposed
May 31, 2011) (to be codified at 45 C.F.R. pt. 164).
34. See Standards for Privacy of Individually Identifiable Health Information, 65 Fed.
Reg. 82,462, 82,464 (Dec. 28, 2000) (to be codified at 45 C.F.R. pts. 160, 164) (“The rule
seeks to balance the needs of the individual with the needs of the society.”); id. at 82,468
(“The task of society and its government is to create a balance in which the individual’s
needs and rights are balanced against the needs and rights of society as a whole.”); id. at
82,472 (“The need to balance these competing interests—the necessity of protecting privacy and the public interest in using identifiable health information for vital public and private purposes—in a way that is also workable for the varied stakeholders causes much of
the complexity in the rule.”).
35. “Individually identifiable health information” is defined as
information that is a subset of health information, including demographic information collected from an individual, and: (1) [i]s created or received by a
health care provider, health plan, employer, or health care clearinghouse;
and (2) [r]elates to the past, present, or future physical or mental health or
condition of an individual; the provision of health care to an individual; or the
past, present, or future payment for the provision of health care to an indi-
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the extent such information does not constitute: (1) an education
record protected under the Family Educational Rights and Privacy Act of 1974 (“FERPA”); (2) a student treatment record excepted
from protection under FERPA; (3) an employment record held by
a covered entity in its role as an employer; or (4) individually
identifiable health information regarding a person who has been
deceased for more than fifty years.36 The name given by the Privacy Rule to the subset of individually identifiable health information described in the previous sentence is PHI.37
The Privacy Rule requires covered entities to adhere to three
different levels of patient permission when using or disclosing
PHI for different activities.38 Again, the varying levels of patient
permission reflect HHS’s desire to appropriately balance the interest of individuals in maintaining the confidentiality of their
health information with a wide range of societal interests in obtaining, using, and disclosing PHI.39 A review of the three levels of
patient permission is necessary before discussing the level of patient permission that is appropriate for fundraising.
The first level of patient permission is actually no patient permission at all. That is, covered entities may freely use and disclose PHI without any form of prior patient permission for their
own treatment,40 payment,41 and health care operations activi42
43
ties, as well as certain public policy activities. For example, a
vidual; and (i) [t]hat identifies the individual; or (ii) [w]ith respect to which
there is a reasonable basis to believe the information can be used to identify
the individual.
Privacy of Individually Identifiable Health Information, 45 C.F.R. § 160.103 (2013).
36. Id. (defining “protected health information”).
37. Id. (using the name “protected health information”).
38. Id. §§ 164.502–.514 (setting forth the use and disclosure requirements).
39. See supra text accompanying note 34.
40. “Treatment” is defined as
the provision, coordination, or management of health care and related services by one or more health care providers, including the coordination or
management of health care by a health care provider with a third party; consultation between health care providers relating to a patient; or the referral
of a patient for health care from one health care provider to another.
45 C.F.R. § 164.501.
41. “Payment” is defined as the “activities undertaken by . . . a health plan to obtain
premiums or to determine or fulfill its responsibility for coverage and provision of benefits
under the health plan” as well as the activities of a “health care provider or health plan to
obtain or provide reimbursement for the provision of health care.” Id.
42. “Health care operations” is defined with respect to a list of activities that are related to a covered entity’s covered functions. Id. These activities include, but are not limited to, conducting quality assessment and improvement activities, conducting training
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covered general practitioner who wishes to consult with a specialist may disclose PHI to the specialist in order to allow the general
practitioner to treat the patient and the Privacy Rule does not require the patient to give his or her prior authorization.44 Likewise,
a covered hospital that treats a patient may send a bill to the patient’s insurer to obtain payment for hospital services rendered.45
Again, the billing may occur without the patient’s prior authorization.46 Similarly, a teaching physician employed by a covered
academic medical center may involve medical students in patient
care, without patient authorization, to enable the students to
learn to practice medicine while under physician supervision.47 A
covered entity that is required by state or other law to disclose
PHI to another individual or entity may do so without patient au48
thorization. By final illustrative, but not exhaustive, example, a
covered entity may disclose a patient’s PHI to a law enforcement
officer in certain situations, including when the covered entity
suspects that the death of the patient may have resulted from
criminal conduct.49 The theory behind these permissions is that
treating patients, allowing health care providers to obtain reimbursement for health care services rendered, training medical
students, complying with state law, and alerting law enforcement
officers to the suspicion of criminal activity outweigh a patient’s
interest in maintaining complete confidentiality.

programs in which medical and other health care students learn to practice health care
under supervision, and arranging for the provision of legal services. Id.; see id. §
164.506(c)(1) (permitting a covered entity to use or disclose PHI for its own treatment,
payment, or health care operations).
43. Covered entities may use and disclose PHI for twelve different public policy activities without the prior written authorization of the individual who is the subject of the information. Id. § 164.512(a)–(l). These public policy activities include, but are not limited
to, uses and disclosures required by law, uses and disclosures for public health activities,
disclosures for law enforcement activities, uses and disclosures for research, and disclosures for workers’ compensation activities. Id. § 164.512(a), (c), (f), (i), (l).
44. Id. § 164.501 (defining treatment to include “consultations between health care
providers relating to a patient”).
45. Id. (defining payment to include “the activities undertaken by [a] health care provider . . . to obtain . . . reimbursement for the provision of health care”).
46. Id. § 164.506(c)(1) (permitting a covered entity to disclose PHI for its own payment
activities).
47. Id. § 164.501 (defining health care operations to include “conducting training programs in which students, trainees, or practitioners in areas of health care learn under supervision to practice or improve their skills as health care providers”).
48. Id. § 164.512(a)(1) (allowing covered entities to “use or disclose protected health
information to the extent that such use or disclosure is required by law and the use or disclosure complies with and is limited to the relevant requirements of such law”).
49. Id. § 164.512(f)(4).
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Under the second level of patient permission, a covered entity
may use and disclose a patient’s PHI for certain activities, but only if the individual is informed in advance of the use or disclosure
and has the opportunity to agree to or prohibit or restrict the use
or disclosure.50 Because the Privacy Rule allows the covered entity
to orally inform the individual of (and capture an oral agreement
or oral objection to) a use or disclosure permitted by these provisions, this level of patient permission is sometimes referred to as
the “oral permission” level, although a more practical written
permission also will suffice. Under the Privacy Rule, a covered
entity can conduct five sets of information uses and disclosures
once the individual who is the subject of the information has been
notified and has either agreed or not objected to the information
51
use or disclosure. These five sets of information uses and disclosures include certain uses and disclosures of directory information, such as name, location, general condition, and religious
52
affiliation; certain uses and disclosures that would allow other
persons to be involved in a patient’s care or payment for care;53
certain uses and disclosures that would help notify, or assist in
the notification of, family members, personal representatives, and
other persons responsible for the care of the individual of the individual’s location, general condition, or death;54 certain uses and
55
disclosures for disaster relief purposes; and certain disclosures
to family members and other persons who were involved in the
individual’s care or payment for health care prior to the individual’s death of PHI that is relevant to that person’s involvement.56
Under this second level of patient permission, the hospital
room number and the general condition of a patient (e.g., “good,”
“fair,” “poor,” “stable”) who has given her permission or who has
not expressed an objection may be disclosed to a visitor who wish57
es to visit an identifiable patient in the hospital. Likewise, a
woman in labor who wishes her partner to be present for her labor and delivery may orally give permission for her health care

50.
51.
52.
53.
54.
55.
56.
57.

Id. § 164.510.
Id. § 164.510(a)(1).
Id. § 164.510(a)(1)(i)(A)–(D).
Id. § 164.510(b)(1)(i).
Id. § 164.510(b)(1)(ii).
Id. § 164.510(b)(4).
Id. § 164.510(b)(5).
Id. § 164.510(a)(1)–(2).
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providers to involve her partner in her care.58 The theory behind
requiring oral permission for these information uses and disclosures is that the patient has an interest in maintaining the confidentiality of her health information; however, the patient also
may have an interest in being visited in the hospital, in obtaining
assistance with the patient’s health care or payment for health
care, and being assisted during a disaster. In addition, the patient’s family may have an interest in visiting the patient in the
hospital, assisting the patient with his or her health care and financial needs, and obtaining assistance during a disaster. The
required oral permission reflects the patient’s interest in maintaining the confidentiality of his or her health information, but
the lack of a requirement for a formal written authorization reflects HHS’s desire to make it easy for the patient to ask for or
agree to receive help.
The third (and highest) level of patient permission is prior
written authorization. In the event that a covered entity would
like to use or disclose PHI for a purpose that is not treatment,
payment, or health care operations, that does not fall within one
of the twelve public policy exceptions, that is not allowed with
oral permission, and that is not otherwise permitted or required
by the Privacy Rule, the covered entity must obtain the prior
written authorization of the individual who is the subject of the
information.59 The Privacy Rule specifies the form of the authorization, including certain required elements and statements that
are designed to place the individual on notice of how the individual’s PHI will be used or disclosed.60 This high level of patient
permission reflects the value HHS places on a patient’s interest
in maintaining the confidentiality of her health information compared to other societal interests that are far removed from the
core functions of covered entities, such as a health care provider’s
interest in selling the patient’s information to a tabloid magazine
or a health plan’s interest in disclosing the patient’s information
to a marketing company to allow the company to market its products and services to the patient.61

58. Id. § 164.510(b)(1)(i).
59. Id. § 164.508(a)(1).
60. Id. § 164.508(c)(1)–(2).
61. See Standards for Privacy of Individually Identifiable Health Information, 65 Fed.
Reg. 82,462, 82,514 (Dec. 28, 2000) (to be codified at 45 C.F.R. pts. 160, 164) (“[C]overed
entities must obtain the individual’s authorization before using or disclosing protected
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With this background, Part II of this article examines the history of HHS’s regulation of the use and disclosure of PHI for
fundraising purposes and identifies HHS’s current placement of
fundraising activities within these three levels of patient permission. As discussed in more detail in Parts IV and V, this article
proposes that HHS move almost all fundraising activities from
the first tier to the third tier of patient permission.
II. THE REGULATION OF THE USE AND DISCLOSURE OF PHI FOR
FUNDRAISING
Again, imagine a covered entity that would like to use or disclose a patient’s PHI in order to raise funds for the covered entity’s own benefit. For example, a general acute care hospital affiliated with a major academic medical center would like to embark
on a capital campaign to raise funds to expand the infrastructure
of, and technological and human resources available through, the
hospital’s medical, surgical, and radiation oncology departments.
To raise funds, the hospital’s major gifts officer would like to access health information in its electronic patient database to select
patients who have received medical, surgical, or radiation oncology services, who had favorable health outcomes, and who live in
certain zip codes known to be associated with a high median
62
family income, or who have other indicators that suggest wealth.
The gifts officer believes that these patients, given their positive
health care experiences, may be inclined to donate money to the
hospital,63 and may have the discretionary funds to do so. These
types of patients are referred to as “grateful patients” and the solicitation of funds from grateful patients is frequently referred to

health information for marketing purposes.”).
62. See GRENZEBACH, GLIER & ASSOCS., GRATEFUL PATIENTS: CRITICAL SUCCESS
FACTORS FOR NAVIGATING HEALTHCARE’S FASTEST GROWING DONOR SEGMENT 3 (2013)
[hereinafter GRATEFUL PATIENTS], available at http://www.donorscape.com/assets/files/
Grateful%20Patient%20White%20Paper%20202013.pdf (providing health care fundraising
advice and noting that “City or Zip code is a common method for segmenting large files,
since, clearly, there are correlations between geographic areas and relative wealth”).
63. See generally After ARRA, CEs Should Tighten Compliance with Fundraising
Rules, ASS’N FOR HEALTHCARE PHILANTHROPY (May 7, 2009), http://sharepoint.ahp.org/
publicationandtools/News/IntheNew/AHPInNews_2009/Pages/AfterARR.aspx?PF=1 [hereinafter AHP, After ARRA] (noting that individuals who have received life-saving treatments and are grateful for such treatments are referred to as “grateful patients” and, “historically, [they are] the highest givers”).
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as “grateful patient fundraising” or “grateful patient philanthropy.”64
After searching its electronic patient database, the gifts officer
identifies the woman described in the opening paragraph of this
article; that is, the forty-year-old woman who had been diagnosed
with stage IV colorectal cancer five years ago, who was given less
than a ten percent chance of living five years, and who, five years
later, is healthy and disease free after a rigorous combination of
surgery, radiation, and chemotherapy.
If the woman’s address is associated with an affluent part of
town, or if other demographic indicators or publicly available data65 reveal actual or probable wealth, the gifts officer may ask the
woman’s treating physician to initiate a private conversation with
the woman regarding the hospital’s health care philanthropy
needs during one of the woman’s follow-up appointments. If the
woman’s address or other publicly available data suggests middle- to upper-middle class, but not wealthy, status, the major gifts
officer may wish to disclose the woman’s home address to a contracted commercial fundraiser, who will send the woman a letter
requesting a monetary donation that would be used to expand the

64. Grateful Patients Build, NONPROFIT TIMES (Sept. 15, 2009), http://www.the nonprofittimes.com/news-articles/grateful-patients-build/ (explaining that grateful patients
and their families are typically the largest donor base for healthcare philanthropy); Lindsey Getz, In Tight Economic Times, Former Patients Become the Focus of Fundraising,
HOSP. & HEALTH NETWORK MAG., Nov. 2008, at 12 (noting that since 2003, forty percent of
major gifts received by the University of Kansas Hospital have come from grateful patients or their families); see, e.g., Scott M. Wright et al., Ethical Concerns Related to Grateful Patient Philanthropy: The Physician’s Perspective, 28 J. GEN. INTERNAL MED. 645, 645
(2012) (“Philanthropy is a vital source of financial support for academic medical centers,
and grateful patients may be the single most important source for substantive philanthropic gifts.”); Page Bullington, First Steps for Successful Grateful Patient Fundraising,
TARGET ANALYTICS, Apr. 2011, at 1, available at http://www.blackbaud.com/files/ resources
/downloads/WhitePaper_FirstStepsForSuccessfulGratefulPatientFundraising.pdf
(“For
any healthcare institution, an excellent source of new donors can be grateful patients.
Programs that reach out to these individuals can form the cornerstones of successful
healthcare fundraising operations.”); Dan Lowman, SENIOR VICE PRESIDENT, GRENZEBACH
GLIER & ASSOCS., Successful Grateful Patient Fundraising Programs: Practical Steps for
Tapping the Fastest Growing Donor Segment in Healthcare (July 1, 2010), available at
http://www.grenzebachglier.com/assets/files/webinars/GG+A%20Webinar%20-%20success
ful%20Grateful%20Patient%20programs%20-%207.1.10.pdf (explaining why grateful patients give more money than do corporations and foundations).
65. See Steven Rum & Scott M. Wright, A Randomized Trial to Evaluate Methodologies for Engaging Academic Physicians in Grateful Patient Fundraising, 87 ACAD. MED.
55, 57 (2012) (listing wealth indicators (including annual income, real estate assets, direct
stock holdings, pension plan value, and investment data estimations) that may be pulled
or estimated from publicly available sources).
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resources available to future patients through the hospital’s oncology department. If the woman is a Medicaid beneficiary, eligibility for which is tied to low-income and low resources, the hospital may wish to spend no time or resources requesting monetary
donations from the woman.
Although the woman described in the preceding paragraphs is
fictitious, there are many examples of actual grateful patients
who have made significant donations to their hospitals and other
health care providers. One well-known example is Annette Bloch,
wife of H&R Block co-owner Richard Bloch.66 The Bloch Cancer
Foundation donated $20 million to a hospital affiliated with the
University of Kansas after Annette received treatment for her
67
breast cancer there.
Our hypothetical does raise several legal issues, however. One
legal issue is whether a treating physician may initiate a private
conversation with the woman regarding the hospital’s health care
philanthropy needs during one of the woman’s follow-up appointments. Since its inception, the Privacy Rule has allowed
physicians to converse with patients regarding a range of activities without the patient’s prior written authorization or other indication of interest in the activity. For example, the Privacy Rule
allows physicians who conduct clinical research to contact their
patients for purposes of making them aware of clinical trials in
which the patients may wish to participate, even without any prior written authorization or other indication from such patients
that they are interested in participating in research.68 HHS reasons that a physician who contacts a patient for purposes of making the patient aware of a clinical trial relevant to the patient’s
illness is engaged in “treatment” activities that fall within the
first level of patient permission discussed in Part I of this arti-

66. Annette Bloch: Advocate, Philanthropist, Survivor, UNIV. OF KAN. CANCER CTR.,
http://www.kucancercenter.org/surviving-cancer/patient-stories/annette-bloch-story (last
visited Apr. 14, 2014).
67. Getz, supra note 64, at 12 (describing the donation made by the R.A. Bloch Cancer
Foundation to the University of Kansas Hospital).
68. U.S. DEP’T HEALTH & HUMAN SERVS., CLINICAL RESEARCH AND THE HIPAA
PRIVACY RULE 4 (2004), available at http://privacyruleandresearch.nih.gov/pdf/clin_resear
ch.pdf (“To contact potential study participants, a researcher may do so, without Authorization from the individual, under the following circumstances: . . . [A] covered health care
provider may discuss treatment alternatives, which may include participating in a clinical
trial, with the patient as part of the patient’s treatment or the covered entity’s health care
operations.”).
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cle.69 Therefore, the Privacy Rule requires no prior written authorization or other indication of interest from the patient.70
The Privacy Rule also allows physicians to initiate private faceto-face conversations with patients regarding available healthrelated and non-health related products and services without any
authorization or other indication that the patient may be interested in purchasing or acquiring such products or services.71 HHS
reasons that the Privacy Rule was not intended to police private
communications between physicians and patients.72 HHS also
reasons that patients who do not want products and services
marketed to them can simply respond that they are uninterested
during the face-to-face conversation.73
The same general rule applies to fundraising. That is, the Privacy Rule does not prohibit a physician from initiating a private,
face-to-face conversation with a patient regarding the hospital’s

69. See id.
70. See id.
71. See Privacy of Individually Identifiable Health Information, 45 C.F.R. §
164.508(a)(3)(i)(A) (2013) (“[A] covered entity must obtain an authorization for any use or
disclosure of protected health information for marketing, except if the communication is in
the form of . . . [a] face-to-face communication made by a covered entity to an individual . . . .”); see also Standards for Privacy of Individually Identifiable Health Information, 65
Fed. Reg. 82,462, 82,545 (Dec. 28, 2000) (to be codified at 45 C.F.R. pts. 160, 164)
(“First . . . [the Privacy Rule] permits a covered entity to use or disclose protected health
information without individual authorization to make a marketing communication if the
communication occurs in a face-to-face encounter with the individual. This provision
would permit a covered entity to discuss any services and products, including those of a
third-party, without restriction during a face-to-face communication. A covered entity also
could give the individual sample products or other information in this setting.”).
72. See Standards for Privacy of Individually Identifiable Health Information, 67 Fed.
Reg. 53,182, 53,190 (Aug. 14, 2002) (to be codified at 45 C.F.R. pts. 160, 164) (“The Department does not intend to police communications between doctors and patients that take
place in the doctor’s office.”).
73. See id. (“In [the face-to-face] context, the individual can readily stop any unwanted
communications, including any communications that may otherwise meet the definition of
‘marketing.’”); see also Frequently Asked Questions, U.S. DEP’T HEALTH & HUMAN SERVS.,
http://www.hhs.gov/ocr/privacy/hipaa/faq/marketing/289.html (last updated Mar. 14, 2006)
(asking, “Are health care providers required to seek a prior authorization before discussing
a product or service with a patient, or giving a product or service to a patient, in a face-toface encounter?” and answering, “No. In face-to-face encounters, the HIPAA Privacy Rule
allows covered entities to give or discuss products or services, even when not healthrelated, to patients without a prior authorization. This exception prevents unnecessary
intrusion into the doctor-patient relationship”); id. (asking, “When is an authorization required from the patient before a provider or health plan engages in marketing to that individual?” and answering, “The HIPAA Privacy Rule expressly requires an authorization
for uses or disclosures of protected health information for ALL marketing communications,
except in two circumstances: 1. When the communication occurs in a face-to-face encounter between the covered entity and the individual . . . .”).
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health care philanthropy needs. The Privacy Rule also would not
prohibit a physician in that same setting from directly asking a
patient for a donation that would benefit the hospital. As a practical matter, no confidentiality concerns are raised because no
other person would be present for the conversation.
Thus, in our hypothetical, the Privacy Rule as it is currently
written would not prohibit the oncologist from initiating a private
conversation with the woman regarding the hospital’s health care
philanthropy needs during one of the woman’s follow-up appointments. Again, HHS believes that the Privacy Rule was not
designed to interfere with private communications between physicians and their patients.74 Although I agree that private, face-toface conversations do not raise confidentiality issues because no
other person is present for the conversation, I argue in a companion article that significant physician involvement in grateful patient fundraising can risk conflicted physician decision making,
health care resource allocation injustices, financial exploitation,
and breach of privacy.75 I manage these concerns by proposing in
that companion article ethical guidelines governing physician in76
volvement in grateful patient fundraising.
A second legal issue relates to situations in which PHI would
be used or disclosed for fundraising activities beyond a private,
face-to-face, physician-patient conversation. For example, many
hospitals also would like their employed, affiliated, or contracted
development officers, major gift officers, institutionally-related
foundation officers, and business associates to be able to use or
disclose PHI in order to call patients on the telephone or mail letters to patients requesting donations. To select the patients who
would receive telephone calls or mailed letters, many hospitals
(and their affiliates and contractors) would like the ability to
search electronic patient databases by certain criteria, such as
treating physician, department of service, health outcome, and
zip code, to try to identify grateful patients who have the financial ability to give. HHS has gone back and forth in proposed and
final regulations over the past fourteen years regarding what, if
any, information may be used by health care providers and their
employed, affiliated, and contracted fundraisers to target patients

74.
75.
76.

See supra notes 72–73 and accompanying text.
See Tovino, Giving Thanks, supra note 9.
Id.
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for receipt of fundraising communications. This article argues
that HHS’s current position, which allows sensitive PHI to be
used and disclosed without prior patient authorization for fundraising purposes, insufficiently protects patient confidentiality.
A. The 1999 Proposed Rule
In its first proposed Privacy Rule, published on November 3,
1999 (“1999 Proposed Rule”), HHS would have required covered
health care providers to obtain a patient’s formal written authorization before using or disclosing any of the patient’s PHI for
fundraising: “Uses and disclosures of protected health information for which individual authorization is required include, but
are not limited to, the following . . . [u]se or disclosure for fund77
raising purposes.” HHS explained in the preamble to the 1999
Proposed Rule that fundraising was sufficiently unrelated to
treatment and payment, the core functions of hospitals and other
covered entities, and therefore prior patient authorization should
be required.78
B. The 2000 Final Rule
Over a year later, on December 28, 2000, HHS issued its first
final Privacy Rule (“2000 Final Rule”) and changed its approach
79
to fundraising. The 2000 Final Rule allowed covered entities to
internally use and externally disclose to BAs and institutionally
related foundations certain classes of PHI for fundraising purpos77. See Standards for Privacy of Individually Identifiable Health Information, 64 Fed.
Reg. 59,918, 60,055 (proposed Nov. 3, 1999) (to be codified at 45 C.F.R. pts. 160–64); see
also Mary Chris Jaklevic, Another Battle: HIPAA Threatens Doc Referrals in Soliciting
Donations, MOD. HEALTHCARE, May 6, 2002, at 14 [hereinafter Jaklevic, Another Battle]
(“A stricter version of the regulations proffered by the Clinton administration and opposed
by the industry would have forbidden hospitals from using patient data for fund raising.”).
78. See Standards for Privacy of Individually Identifiable Health Information, 64 Fed.
Reg. at 59,941 (“[W]e determined that it would be helpful to identify activities that, in our
opinion, are sufficiently unrelated to the treatment and payment functions to require a
[sic] individual to authorize use of his or her information. We want to make clear that
these activities would not be prohibited, and do not dispute that many of these activities
are indeed beneficial to both individuals and the institutions involved. Nonetheless, they
are not necessary for the key functions of treatment and payment and therefore would require the authorization of the individual before his/her information could be used. These
activities would include but would not be limited to: . . . The use or disclosure of information for fund raising purposes.”).
79. See Standards for Privacy of Individually Identifiable Health Information, 65 Fed.
Reg. 82,462 (Dec. 28, 2000) (to be codified at 45 C.F.R. pts. 160, 164).
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es without prior authorization.80 That is, covered entities were allowed to use or disclose demographic information about an individual as well as dates relating to the provision of health care to
an individual for the purpose of raising funds for the covered entity’s own benefit without obtaining prior authorization from the
individual.81 In the 2000 Final Rule, HHS imposed five requirements on fundraising efforts engaged in without prior authorization. First, the fundraising must be for the covered entity’s own
benefit.82 That is, a covered entity could not use or disclose an individual’s PHI to help a second organization raise funds for the
second organization’s benefit.83 Second, the covered entity must
include a statement in a document called a notice of privacy practices informing individuals that their PHI may be used and dis84
closed for fundraising purposes. Third, the covered entity must
include in its fundraising communications a description of how
individuals may opt out of receiving further fundraising commu85
nications. Fourth, the covered entity must make reasonable efforts to ensure that individuals who opt out of receiving future
fundraising communications are not sent such communications.86
Finally, the PHI used or disclosed by the covered entity must be
limited to demographic information and dates of health care.87
Other information, such as an individual’s diagnosis, the specific
treatments provided to the individual, the name of the individual’s treating physician, or the name of the hospital department in
which the individual received health care, could not be used or
disclosed without prior authorization.88 Covered entities that ad80. Id. at 82,514 (“In the final rule, we narrow the circumstances under which covered
entities must obtain the individual’s authorization to use or disclose protected health information for fundraising purposes.”).
81. Id.
82. Id. at 82,820 (“A covered entity may use, or disclose . . . the following [PHI] for the
purpose of raising funds for its own benefit . . . .”).
83. Id. at 82,514 (“Any use or disclosure for fundraising purposes that does not meet
the requirements . . . requires authorization. Specifically, covered entities must obtain the
individual’s authorization to use or disclose [PHI] to raise funds for any entity other than
the covered entity. For example, a covered entity must have the individual’s authorization
to use [PHI] about the individual to solicit funds for a non-profit organization that engages
in research, education, and awareness efforts about a particular disease.”).
84. Id. at 82,820.
85. Id.
86. Id.
87. Id. (“A covered entity may use, or disclose . . . the following [PHI] for its own benefit, without an authorization . . . (i) Demographic information relating to an individual;
and (ii) dates of health care provided to an individual.”).
88. See, e.g., Christopher Cloud, Fund Raising Hits a Privacy Barrier: HIPAA Rule
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hered to these requirements were considered to be engaged in
“health care operations” within the first level of patient permission described in Part I of this article; thus, no prior authorization was required.89
The fundraising approach HHS selected in its 2000 Final Rule
appears to have been shaped in large part by the comments HHS
received during the notice-and-comment rulemaking process. According to HHS, many commenters argued that it would be “time
consuming and costly” for non-profit health care providers to obtain prior patient authorization for fundraising.90 These commenters argued that an authorization requirement could “lead to
a decrease in charitable giving.”91 Comments such as these perhaps explain HHS’s removal of the authorization requirement
that was proposed in the 1999 Proposed Rule.
The limitations HHS imposed on permissible fundraising activities in its 2000 Final Rule also appear to have been shaped by
public comment. According to HHS, numerous commenters explained that they did not need access to all PHI, just patient
names, addresses, and telephone numbers, to carry out fundraising, and that the use or disclosure of other information by covered
entities could “unnecessarily intrude[] on individual privacy.”92 In
addition, several commenters explained that “disease or condition-specific letters requesting contributions, if opened by the
wrong person, could reveal personal information about the in-

Will Force Healthcare Organizations to Rethink Development Outreach, MOD.
HEALTHCARE, Jan. 13, 2003, at 21 (“Unless a patient signs a special authorization, the
HIPAA privacy rule will limit fund-raisers’ access to a patient’s name, address, age, gender, insurance status and the date the individual was treated. Many analysts interpret the
privacy rule to mean that fund-raisers cannot access information about the doctor or practice area where a patient was treated.”); Mary Chris Jaklevic, Healthcare Donations
Surge, MOD. HEALTHCARE, Sept. 10, 2001, at 34 [hereinafter Jaklevic, Healthcare Donations Surge] (explaining that under the 2000 regulations, development officers will not
have access to patient medical data for fundraising; “[f]or example, fund-raisers could not
determine which patients received cancer care, and therefore would be likely candidates to
hit up for funding of a new linear accelerator”).
89. See Standards for Privacy of Individually Identifiable Health Information, 65 Fed.
Reg. at 82,546 (“[I]n the final rule we define fundraising on behalf of a covered entity to be
a health care operation.”); id. at 82,804 (defining health care operations to include
“[c]onsistent with the applicable requirements of § 164.514 . . . fundraising for the benefit
of the covered entity”).
90. Id. at 82,716.
91. Id. at 82,718 (“We agree with commenters that our proposal could have adversely
effected charitable giving, and accordingly make several modifications to the proposal.”).
92. Id.
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tended recipient.”93 These comments perhaps explain HHS’s requirement in the 2000 Final Rule that only demographic information and dates of health care could be used or disclosed for
fundraising.
Certainly not everyone agreed with HHS’s approach to fundraising in the 2000 Final Rule. Joel Simon, Director of Gift Planning at the charitable foundation of Greater Baltimore Medical
Center, responded to the final rule by criticizing its limitations on
ways of searching for grateful patients: “‘You need to find the
needle in the haystack of 240,000, and HIPAA took away our
magnet.’”94
C. The 2009 HITECH Legislation
The federal government’s approach to fundraising held steady
until ARRA began working its way through Congress in early
2009. On January 28, 2009, an amendment to ARRA proposed to
the House would have struck fundraising from the definition of
“health care operations,” thereby removing fundraising from the
first level of patient permission and moving it to the third; that is,
covered entities would be required to obtain prior written authorization for all uses and disclosures of PHI for fundraising.95 The
amendment, which was unsuccessful, was patient advocates’ final
pre-ARRA attempt to give more weight to health information con96
fidentiality than to health care philanthropy.
Less than three weeks later, on February 17, 2009, President
Obama signed ARRA, including HITECH, into law.97 HITECH

93. Id.
94. Jaklevic, Healthcare Donations Surge, supra note 88, at 34.
95. See 155 CONG. REC., H702 (daily ed. Jan. 28, 2009) (proposing to amend ARRA by
stating: “Fundraising.—Fundraising for the benefit of a covered entity shall not be considered a health care operation for purposes of section 164.501 of title 45, Code of Federal
Regulations”).
96. See AHP, After ARRA, supra note 63 (“Prior to final passage of ARRA, there was a
pitched battle between ardent patient privacy advocates and those representing health
care providers and employers about the extent to which the existing protections should be
strengthened. . . . [Patient] [a]dvocates convinced House members to toss the word ‘fundraising’ . . . . [Then, the Association for Healthcare Philanthropy] and other organizations
launched a lobbying effort, saying the Office for Civil Rights had told them that in six
years it had received no complaints of privacy violations related to fundraising. The [philanthropy] groups were victorious, and the House-Senate conference committee removed
the sentence dealing with fundraising but retained the restrictions on marketing.”).
97. Ed Jones, ARRA’s HITECH Privacy Provisions Apply HIPAA Security Rule to
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contained two consecutive provisions that specifically addressed
fundraising and directed HHS to make certain changes to the
Privacy Rule’s fundraising provisions. The first provision required HHS to provide by rule that “any written fundraising
communication that is a healthcare operation . . . shall, in a clear
and conspicuous manner, provide an opportunity for the recipient
of the communications to elect not to receive any further such
communication.”98 In the second provision, HITECH stated:
“When an individual elects not to receive any further such communication, such election shall be treated as a revocation of authorization . . . .”99
The two statutory provisions were curious for several reasons.
First, HHS already required individuals be provided the opportunity to elect not to receive further fundraising communications,
so the only new requirement in the first provision was that the
opportunity given to the individual to opt out must be “clear and
100
conspicuous.” The statutory requirement for a “clear and conspicuous” opportunity to opt out was unusual for federal health
law. That is, Congress usually sets broad policy mandates in legislation and HHS usually establishes detailed implementation
procedures in regulations.101 Here, Congress included in its legislation detailed implementation provisions addressing the manner
of information presentation.
Moreover, the second HITECH provision did not really make
sense. Since individuals were not required to authorize covered
entities to use their limited demographic information and dates of
health care for fundraising under the 2000 Final Rule, HITECH’s
requirement that a patient’s election not to receive further communications be treated as a revocation of such authorization was
odd.102

Business Associates, HIPAA.COM, http://www.hipaa.com/2009/02/arras-hitech-privacy-pro
visions-apply-hipaa-security-rule-to-business-associates/ (last visited Apr. 14, 2014).
98. Health Information Technology for Economic and Clinical Health Act, Pub. L. No.
111-5, § 13406(b), 123 Stat. 115, 269 (2009).
99. Id.
100. Id.; see AHP, After ARRA, supra note 63 (reporting that a HIPAA attorney
thought it unusual for HITECH to have “such specific implementation details, typically
left up to rules issued by federal agencies” especially when “the new provision essentially
repeats requirements in the privacy rule”).
101. See id.
102. See, e.g., Letter from Claudia A. Looney, Senior Vice President of Dev., Children’s
Hosp. of L.A., to U.S. Dep’t of Health & Human Servs. 2 (Aug. 25, 2010) (“The use of the
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D. The 2010 Proposed Rule
After President Obama signed HITECH into law, the health
care industry eagerly awaited HHS’s interpretation of the curious
HITECH provisions.103 On July 14, 2010, HHS released a proposed rule (“2010 Proposed Rule”) that would modify the Privacy
Rule in accordance with HITECH.104 In the preamble preceding
the proposed rulemaking, HHS highlighted the extent to which
the rulemaking would strengthen confidentiality protections in
the context of fundraising by imposing new limitations on the use
and disclosure of PHI for fundraising.105 Later in the rulemaking,
in a section designed to highlight the benefits that would flow to
individuals as a result of the rulemaking, HHS mentioned again
the extent to which it was strengthening confidentiality protections by imposing restrictions on fundraising.106
Indeed, part of HHS’s 2010 Proposed Rule would have
strengthened individuals’ confidentiality protections in the context of fundraising. As required by HITECH, HHS proposed to
strengthen an individual’s ability to recognize the opportunity to
opt out of receiving future fundraising communications by requiring the opt-out language to be presented to individuals in a “clear
107
and conspicuous” manner. Although not required by HITECH,
HHS also proposed to require that the method for an individual to

term ‘authorization’ is confusing in the context of an ‘opt-out.’ Revocation of authorization
for an opt-out seems to require using a legal document similar to the HIPAA Authorization Form currently used by fundraisers when there is need to use or disclose . . . .”).
103. See, e.g., Judd A. Harwood, Have You Seen My HIPAA Regulations, BIRMINGHAM
MED. NEWS BLOG (Nov. 21, 2012, 7:52 AM), http://birminghammedicalnews.blogspot.
com/2012/11/have-you-seen-my-hipaa-regulations.html (referencing the health care industry’s long wait for the Final Regulations); Bill Mountcastle, HIPAA Rule Brings about Favorable Changes to Fundraising, HEALTH PHILANTHROPY SERVS. GRP. (Mar. 26, 2013),
http://www.health-philanthropy.com/index.php?option=com_lyftenbloggie&view=entry&
category=bloggies&id=5%3Ahipaa-rule-brings-about-favorable-changes-to-fundraising&It
emid=15 (stating that the Final Regulations give “long-awaited clarification regarding the
use of health information for hospital fundraising”).
104. See Modifications to the HIPAA Privacy, Security, and Enforcement Rules Under
the Health Information Technology for Economic and Clinical Health Act, 75 Fed. Reg.
40,868 (proposed July 14, 2010) (to be codified at 45 C.F.R. pts. 160, 164).
105. See id. at 40,869 (“These provisions . . . [establish] new limitations on the use and
disclosure of protected health information for . . . fundraising purposes . . . .”).
106. Id. at 40,909 (“Also, individuals’ rights with respect to fundraising communications would be strengthened.”).
107. Id. at 40,896, 40,922 (“With each fundraising communication sent to an individual
under this paragraph, a covered entity must provide the individual with a clear and conspicuous opportunity to elect not to receive any further fundraising communications.”).
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elect not to receive further fundraising communications not pose
an “undue burden” or be “more than nominal.”108 In the preamble
to the 2010 Proposed Rule, HHS encouraged covered entities to
“consider the use of a toll-free phone number, an e-mail address,
or similar opt out mechanism that would provide individuals with
a simple, quick, and inexpensive way to opt out of receiving future communications.”109 HHS also explained its belief that requiring individuals to opt out by sending a letter through the U.S.
mail would constitute an undue burden.110 HHS further proposed
that a covered entity not be able to condition treatment or payment on an individual’s choice with respect to receiving fundrais111
ing communications. This proposal, HHS believed, would implement the curious language in HITECH that an election by an
individual not to receive further fundraising communications be
treated as a revocation of authorization.112 HHS’s final proposal
designed to strengthen confidentiality protections in the context
of fundraising was a proposal that covered entities not be able to
send fundraising communications to an individual who had elected not to receive such communications.113 Before, covered entities
only had to make “reasonable efforts” to ensure that those individuals who had opted out of receiving fundraising communications were not sent such communications.114 Now, covered entities
would be expected to actually abide by an individual’s request not
to receive further fundraising communications.115
In addition to these proposals that were highly touted as increasing confidentiality protections in the context of fundraising,116 HHS also quietly solicited public comment on other provisions that would decrease confidentiality protections. That is,
HHS solicited public comment on whether to expand the classes
of PHI that a covered entity may use and disclose for fundraising

108. See id.
109. Id. at 40,886.
110. Id.
111. Id. at 40,896, 40,922 (proposing 45 C.F.R. § 164.514(f)(1)(ii)(C)).
112. Id. at 40,896–97.
113. Id. at 40,897, 40922–23.
114. Id. at 40,897 (internal quotation marks omitted); see also supra text accompanying
note 86.
115. See Modifications to the HIPPA Privacy, Security, and Enforcement Rules Under
the Health Information Technology for Economic and Clinical Health Act, 75 Fed. Reg. at
40,897.
116. See supra text accompanying note 105.
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purposes from just demographic information and dates of health
care to other information, including the name of the hospital department that provided health care services to the individual.117
Explaining its solicitation of public comment on this topic, HHS
cited concerns expressed by some covered entities that additional
classes of information were needed to successfully engage in
grateful patient fundraising.118
E. The 2013 Final Rule
Almost four years after President Obama signed HITECH into
law, HHS issued its Final Regulations implementing HITECH.
Published on January 25, 2013,119 and technically corrected on
June 7, 2013,120 the Final Regulations contain both expected and
surprising provisions that increase and decrease confidentiality
protections in the context of fundraising, respectively.
As expected, and as required by HITECH, HHS added a requirement that the opportunity to elect not to receive further
fundraising communications be clear and conspicuous: “With each
fundraising communication made to an individual under this
paragraph, a covered entity must provide the individual with a
clear and conspicuous opportunity to elect not to receive any further fundraising communications.”121 Although not required by
HITECH, HHS also added other provisions it had proposed that

117. See Modifications to the HIPPA Privacy, Security, and Enforcement Rules Under
the Health Information Technology for Economic and Clinical Health Act, 75 Fed. Reg. at
40,897 (“In addition to the above modifications proposed in response to the HITECH Act,
we also solicit public comment on the requirement at § 164.514(f)(1) which limits the information a covered entity may use or disclose for fundraising demographic information
about and dates of health care service provided to an individual.”).
118. Id. (“Since the promulgation of the Privacy Rule, certain covered entities have
raised concerns regarding this limitation, maintaining that the Privacy Rule’s prohibition
on the use or disclosure of certain treatment information without an authorization, such
as the department of service where care was received and outcomes information, harms
their ability to raise funds from often willing and grateful patients.”).
119. See Modifications to the HIPAA Privacy, Security, Enforcement, and Breach Notification Rules under the Health Information Technology for Economic and Clinical Health
Act and the Genetic Information Nondiscrimination Act, 78 Fed. Reg. 5566, 5700 (Jan. 25,
2013) (to be codified at 45 C.F.R. pts. 160, 164).
120. See Technical Corrections to the HIPAA Privacy, Security, and Enforcement
Rules, 78 Fed. Reg. 32,466, 32,466 (June 7, 2013) (to be codified at 45 C.F.R. pt. 160, 164).
121. See Modifications to the HIPAA Privacy, Security, Enforcement, and Breach Notification Rules under the Health Information Technology for Economic and Clinical Health
Act and the Genetic Information Nondiscrimination Act, 78 Fed. Reg. at 5700; see also id.
at 5618 (summarizing HITECH’s new fundraising language).
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supported an individual’s ability to opt out of receiving further
fundraising communications. For example, HHS finalized the
provision requiring the opt-out method not to pose an undue burden or exceed a nominal cost.122 HHS also finalized the provision
it had proposed prohibiting covered entities from making fundraising communications to individuals who had opted out of receiving further communications.123 Moreover, HHS finalized the
provision prohibiting covered entities from conditioning “treatment or payment on [an] individual’s choice with respect to the
receipt of fundraising communications.”124 Although not in the Final Regulations, HHS also clarified in the preamble to the Final
Regulations that covered entities must not use or disclose more
than the minimum amount of information necessary to accom125
plish their fundraising activities. All four of these regulatory
provisions plus the preamble clarification may be viewed as increasing the confidentiality protections available to individuals
who wish not to have their PHI used or disclosed for fundraising
purposes.
As it did in its 2010 Proposed Rule, in the Final Regulations
HHS made much of the way these new provisions would increase
confidentiality in the context of fundraising. On the first page of
the preamble to the Final Regulations, HHS explained that it was
“[s]trengthen[ing] the limitations on the use and disclosure of
protected health information for . . . fundraising purposes.”126
HHS stated several times thereafter that the Final Regulations
“establish new limitations on the use and disclosure of protected
health information for . . . fundraising purposes.”127
Notwithstanding the emphasis HHS gave to its heightened
confidentiality protections in the context of fundraising, the Final
Regulations also contained somewhat surprising provisions that
allow covered entities to expand the classes of PHI that may be
used or disclosed for fundraising purposes.128 In addition to demo-

122. See id. at 5700.
123. Id.
124. Id.
125. Id. at 5622.
126. Id. at 5566.
127. Id. at 5568.
128. Id. at 5620 (“We generally adopt the proposals in the final rule, as well as allow
certain additional types of protected health information to be used or disclosed for fundraising purposes.”).
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graphic information (including name, address, other contact information, age, gender, and date of birth) and dates of health care
provided to an individual, the Final Regulations now allow covered entities to use and disclose information relating to the department of service from which the individual received care, as
well as information regarding the individual’s treating physician
and health outcomes.129 HHS explained that department of service
information, treating physician information, and outcome information were the three categories of information most frequently
identified by commenters as necessary for targeting fundraising
communications to potentially grateful patients.130
Although the Final Regulations do not provide further detail
about these three classes of PHI, HHS clarifies in its preamble
language that department of service information includes information about the general department from which the patient received treatment, such as the cardiology department, the oncolo131
gy department, or the pediatrics department. As far as outcome
information, HHS clarifies in the preamble that covered entities
would be permitted to use and disclose any information regarding
the death of the individual or any other sub-optimal result of
treatment or services in order to screen out certain individuals for
the receipt of fundraising communications.132
In the preamble to the Final Regulations, HHS did not specifically identify the exact number of commenters who persuaded
them to expand the classes of PHI that could be used or disclosed
for fundraising.133 A careful reading of the preamble suggests that
they received more comments in favor of expanding the classes of
PHI that could be used or disclosed for fundraising than comments opposed to such expansion. In one part of the preamble,
HHS provides: “[T]he vast majority of commenters supported allowing the use or disclosure of additional protected health information for fundraising.”134 Later, HHS explained that “a small
129. Id. at 5700; see also id. at 5622 (“[T]his final rule also allows covered entities to
use and disclose department of service information, treating physician information, and
outcome information for fundraising purposes.”).
130. Id. at 5622.
131. Id.
132. Id.
133. See infra Part IV for a detailed discussion of the number and contents of the comments received by HHS.
134. Modifications to the HIPAA Privacy, Security, Enforcement, and Breach Notification Rules under the Health Information Technology for Economic and Clinical Health Act
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minority of commenters opposed allowing the use of additional
protected health information to target fundraising efforts, citing
privacy concerns with doing so.”135
In summary, HHS changed tack with respect to its approach to
fundraising three times in the last decade and a half. In its 1999
Proposed Rule, HHS would have required prior written authorization for all PHI uses and disclosures for fundraising. That is, in
2000, HHS initially classified fundraising as requiring the third
(and highest) level of patient permission: prior written authorization. Over a year later, in its 2000 Final Rule, HHS decided to
impose fewer confidentiality restrictions on PHI used and disclosed for fundraising by allowing two classes of PHI (i.e., demographic information related to an individual and dates of health
care provided to an individual) to be used and disclosed for fundraising without prior written authorization. That is, in 2000 HHS
classified the use and disclosure of these two classes of PHI as
“health care operations” within the first level of patient permission, requiring no prior written authorization. Thirteen years later, in 2013, HHS in its Final Regulations removed additional confidentiality restrictions on the use and disclosure of PHI for
fundraising by allowing additional classes of PHI (i.e., department of service, treating physician, and outcome information) to
be used and disclosed for fundraising without prior written authorization. That is, HHS increased the number of information
uses and disclosures that fall within the first level of patient
permission, thus requiring no prior written authorization. The
question is whether the current approach is appropriate. As discussed in more detail in Parts IV and V, I believe it is not.
III. THE BUSINESS OF HEALTH CARE PHILANTHROPY
To determine whether HHS’s current approach to fundraising
is appropriate, an individual’s interest in maintaining the confidentiality of his or her health information must be balanced
against a health care provider’s interest in obtaining, using, and
disclosing PHI for fundraising purposes. This balancing requires

and the Genetic Information Nondiscrimination Act, 78 Fed. Reg. at 5620. According to
HHS, “These commenters stated that the use of additional protected health information
would streamline their fundraising efforts and ensure that individuals were sent communications about campaigns that would be meaningful to their experiences.” Id.
135. Id.
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a careful examination of the business of health care philanthropy,
including the many benefits.
In 2012, the most recent year for which data is available, charitable giving in all industries totaled $316.23 billion.136 Approximately three-quarters of that amount—$228.93 billion in 2012—
came from individuals; that is, non-corporations and nonfoundations.137 Charitable giving to health organizations, the subject of this article, totaled $28.12 billion in 2012.138 Historically,
more than three-quarters of the amount given to health organizations has come from individuals.139
Philanthropy has helped found, build, and maintain some of
the country’s oldest and finest healthcare institutions. New Orleans’s historic Charity Hospital “was founded as a result of a crea140
tive estate plan of Jean Lois, a French seaman, in 1735.” Los
Angeles’s famous Cedars-Sinai Medical Center “was dedicated, in
1902, through the generosity of the city’s Jewish community.”141
San Francisco’s French Hospital, “California’s oldest existing
hospital, was established by a relief society” founded for the purpose of serving the sick and furnishing assistance to individuals
142
without resources, among other purposes.

136. See Mark Hrywna, Giving Gains, Estimated at $316.23 Billion for 2012,
NONPROFIT TIMES (June 18, 2013), http://www.thenonprofittimes.com/news-articles/giv
ing-gain-estimated-at-316-23-billion-for-2012/; Giving USA: Charitable Donations Grew in
2012, But Slowly, Like the Economy, LILLY FAMILY SCH. OF PHILANTHROPY (June 18,
2013), http://www.philanthropy.iupui.edu/news/article/giving-usa-2013 [hereinafter Giving
USA].
137. See Giving USA, supra note 136.
138. See id. For an overview of numbers reported by other sources and for previous
years, see Rum & Wright, supra note 65, at 55 (reporting that charitable giving to the
health care industry, including academic medical centers, health systems, and community
hospitals, totaled $4.8 billion in 2009); Michael L. Bentz et al., Fundraising and Philanthropy in Plastic Surgery: An Essential Tool for Academic Excellence, 127 PLASTIC
RECONSTRUCTIVE SURGERY 2108, 2108 (2011) (reporting that educational institutions, including academic medical centers, received approximately seventeen percent of total charitable giving and that health initiatives received seven percent of total charitable giving);
Getz, supra note 64, at 12 (reporting that the total amount donated to hospitals was $7.9
billion in 2006 and $8.3 billion in 2007).
139. See, e.g., Lowman, supra note 64, at 3 (providing data from 2008 and noting that
of the $8.6 billion in donations given to health care institutions, eighty-five percent of
those donations came from individuals; that is, non-foundations and non-corporations).
140. Edie E. Zusman et al., Philanthropy Funding for Neurosurgery Research and Program Development, 73 NEUROSURGERY 177, 177 (2013).
141. Id.
142. Id.
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The largest known gift to an American health care institution
is the $400 million gift given in 2007 by businessman Denny Sanford to the Sioux Valley Hospitals & Health System, located in
Sioux Falls, South Dakota.143 The health system has since been
renamed Sanford Health.144 Other illustrative major gifts to
American health care institutions include the $75 million given
by the Schmidt Family Foundation to Boca Raton Community
Hospital in Florida,145 the $60 million gift given by A.B. Hudson to
Shriners Hospital for Children,146 the $4 million gift given by
Richard M. and Yvonne Hamlin to Summa Health System in
Ohio,147 and the $100 million regularly raised through gifts each
148
year to New York University’s Langone Medical Center.
Philanthropic donations support a wide variety of health care
149
initiatives and related educational missions. In the context of
academic medical centers, which typically include a medical
school and at least one affiliated teaching hospital,150 philanthro-

143. See Kelby Krabbenhoft, Philanthropy: A Priceless Lesson in Healthcare Leadership—The Sanford Health Story, 24 FRONTIERS HEALTH SERVS. MGMT. 3, 4 (2008) (describing how Denny Sanford’s $400 million gift to support the institution that was renamed Sanford Health “(the largest known gift to an American healthcare organization)”
came about); Loren Shook, Building a Culture of Philanthropy from the Inside Out, 24
FRONTIERS HEALTH SERVS. MGMT. 23, 23 (2008) (discussing the $400 million Sanford
Health gift); Susan Kreimer, Mega Gifts Let Hospitals Rapidly Expand Their Missions,
HOSPS. & HEALTH NETWORKS, Mar. 2007, at 26 (discussing the $400 million Sanford
Health gift).
144. See About Us, SANFORD LUVERNE, http://www.sanfordluverne.org/about/ (last visited Apr. 14, 2014) (noting that the Sioux Valley Health System was renamed Sanford
Health after Danny Sanford’s $400 million gift).
145. See Stephanie Strom, Florida: $75 Million Donated to Hospital, N.Y. TIMES, Jan.
31, 2007, at A15 (“The Boca Raton Community Hospital announced that it had received
$75 million from the Schmidt Family Foundation, one of the largest gifts given to a hospital. The money will help underwrite a new academic medical center focusing on hospital
safety.”).
146. See Tammy Robins, Shriners Hospitals for Children Receives $60 Million Donation
Largest Donation in Organization’s History, LADUE-FRONTENAC PATCH (Missouri), (Oct.
16, 2011), http://ladue-frontenac.patch.com/groups/around-town/p/shriners-hospitals-forchildren-receives-60-million-d7e9224de9b.
147. See Summa Health System Receives Largest Philanthropic Gift in Organization’s
History, SUMMA HEALTH SYS. (July 23, 2013), http://www.summahealth.org/pressroom/all
news/2013/summa-health-system-receives-largest-philanthropic-gift-in-organizations-hist
ory.
148. See Grateful Patients Build, supra note 64.
149. See Park H. Haussler, Philanthropy for Patient Care, HEALTHCARE FIN. MGMT.,
Dec. 1982, at 6.
150. Cf. Joseph V. Simone, Understanding Academic Medical Centers: Simone’s Maxims, 5 CLINICAL CANCER RES. 2281, 2281 (1999) (describing the educational and patient
care components of an academic medical center).
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py has historically supported educational efforts,151 research programs,152 clinical initiatives,153 and building or other academic infrastructure support.154
In the non-academic health care setting, health care buildings,
including whole hospitals as well as wings, departments, wards,
units, and centers of hospitals, have been the traditional beneficiaries of philanthropic efforts.155 Historically, giving also has
funded the acquisition and maintenance of expensive medical
equipment, including x-ray machines, computed tomography
scanners, magnetic resonance imaging scanners, and positron
emission tomography scanners.156 Several decades ago, when
third-party payers reimbursed health care primarily on a retro157
spective cost basis, donations designed to cover daily operating
costs, such as the cost of a patient’s daily hospital bed charge,
were discouraged because such donations (viewed by accountants
and auditors as reductions in costs) were required to be reported
to third party payers and subtracted from the reimbursement requested by the health care provider.158 In the 1980s and 1990s, as

151. See Bentz et al., supra note 138, at 2111. Educational expenses include hard copy
and computer based learning materials, resident travel for presentation of papers and
teaching course attendance, visiting professorships, named lectureships, and international
surgery mission efforts, among others. Id.
152. Id. Research programs include “basic science, translational, and clinical research
programs.” Id. at 2111 tbl.3.
153. Id.
154. Id. Building and academic infrastructure support include the development or improvement of buildings or areas within buildings, the purchase or donation of pieces of
equipment, chairs, professorships, and/or program directorships. See id. at 2111.
155. See Haussler, supra note 149, at 6 (“Bricks and mortar . . . have been the primary
beneficiaries of charitable giving.”).
156. See Les Cave et al., Philanthropy Makes a Difference: CHRISTUS Health Reaps
the Benefits of Its Successful Community Efforts in Southern Texas, HEALTH PROGRESS,
Jan.-Feb. 2008, at 44 (“Many philanthropists are attracted to the idea of making contributions to build new buildings and acquire high technology like CAT Scans, MRIs and Cath
labs, especially if this ‘health care’ comes complete with naming rights.”); Haussler, supra
note 149, at 6 (“[E]quipment and other capital acquisitions have been the primary beneficiaries of charitable giving.”).
157. See, e.g., LOUIS C. GAPENSKI, FUNDAMENTALS OF HEALTHCARE FINANCE 70 (2d ed.
2013) (explaining that cost-based reimbursement involves a third-party payer who agrees
to reimburse the health care provider for the actual costs incurred in providing health care
to the insured population; cost-based reimbursement is retrospective in the sense that reimbursement is based on the actual services that were delivered to the patient in the
past).
158. See Haussler, supra note 149, at 6 (“Since the beginning of cost-based reimbursement, the industry has discouraged the endowment of free beds, or the underwriting of
operation costs. In our efforts to ‘maximize’ reimbursement, we have noted that any reduction of cost shares the gift with third-party payors, and we have concluded in most cases
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third-party payers moved towards prospective payment systems,159 the health care industry began to change its approach to
philanthropy, including by encouraging donations that could be
put towards daily operating expenses.160
Today, health care institutions engage in fundraising to support an even wider variety of health care initiatives and related
educational missions. Academic medical centers continue to engage in fundraising to satisfy educational needs, research programs, clinical initiatives, and building and infrastructure support.161 Nonprofit health care organizations engage in fundraising
to provide resources to their community-based hospitals and clinics and to improve access to health care and other services for the
162
uninsured and under-insured. Many private health care foundations use philanthropy to serve the economically poor and under-served, including women, children, and seniors who live in
the community served by the foundation.163 Health care philanthropy is also used to improve the public’s health through preventhat it is not the intention or desire of the donor to have such sharing.”).
159. A prospective payment system may be defined as a payment system in which the
rates paid by third-party payers are determined by the payer before health care services
are provided and in which payments are not directly related to a health care provider’s
costs or charges. See GAPENSKI, supra note 157, at 71–72.
160. See Cave et al., supra note 156, at 44 (“And, of course, with the reimbursement
challenges hospitals and acute care face today, it often is essential to raise money through
philanthropy to supplement the limited insurance and patient payments received.”);
Haussler, supra note 149 at 6 (“Now is the time for the healthcare industry to consider a
change in approach to philanthropy. Two reasons point to this conclusion: Cost-based reimbursement will be soon a relic of the past and, [t]here are unmet patient and institutional financial needs. As the healthcare industry moves into the competitive marketplace,
reasonable provision for capital expansion, education and operations must be built into the
charge structure. . . . Funding from gifts and bequests for payment of specific patient
charges can be a means through which an institution may reduce uncollectible accounts,
thereby strengthening the bottom line.”).
161. Bentz et al., supra note 138, at 2111; see also Rum & Wright, supra note 65, at 55
(“At academic health centers and hospitals, these monies help to fund varied needs including capital projects, research programs, educational initiatives, financial aid, and endowments. These gifts clearly support the tripartite academic health center mission of patient
care, research, and education.”); Wright et al., supra note 64, at 645 (“Philanthropic contributions to academic medical centers from grateful patients support research, patient
care, education, and capital projects.”).
162. See, e.g., Cave et al., supra note 156, at 44 (“[T]he [CHRISTUS] fund’s intent is to
provide resources to community-based, not-for-profit organizations whose vision, mission
and goals are consistent with those of CHRISTUS Health. Creating access to health care
and other services for the uninsured and under-insured in communities served by
CHRISTUS Health gives specificity to the grants awarded.”).
163. See, e.g., id. at 47 (noting that the St. Joseph’s Community Foundation located in
Paris, Texas, “focuses on programs that serve the economically poor and under-served,
women and children and seniors . . . .”).
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tion and wellness programs and through the offering of basic
health care and disease management for individuals without
health insurance.164 Health care philanthropy is used to support a
wide range of medical specialties and patient care needs, including neurosurgery,165 obstetrics and gynecology,166 plastic surgery,167
psychiatry,168 and rare diseases,169 among others. In short, health
care philanthropy now supports a variety of medical specialties
and health care needs in a broad range of communities and settings. That is, health care philanthropy has moved well beyond
its historic purpose of providing financial support of hospital
“bricks and mortar.”170
Philanthropy is said to be one of the only ways that some
health care institutions can survive in the current health care environment, which is characterized by expensive medical technologies, high uncompensated health care costs, inadequate Medicare
and Medicaid reimbursement, and rising health care compliance
171
costs associated with health care reform. In addition, philan-

164. See id. at 45 (“[The intent of philanthropy can be] to improve the public’s health
through prevention and wellness programs or . . . to offer primary care and disease management for uninsured.”).
165. See Zusman et al., supra note 140, at 177 (“In times of fiscal and political uncertainty, philanthropy has become an increasingly important mechanism for building, maintaining, and expanding neurosurgical research programs.”).
166. See Frank A. Chervenak et al., Ethics: An Essential Dimension of Soliciting Philanthropic Gifts from Donors, 203 AM. J. OBSTETRICS & GYNECOLOGY 540, 540 (2010) (“Obstetrics and gynecology continues to experience fiscal pressures that challenge its core
missions. In such an increasingly economically unforgiving environment, philanthropy will
become a major source of revenue.”).
167. See, e.g., Bentz et al., supra note 138, at 2108 (addressing the need for fundraising
in the context of academic plastic surgery).
168. See Herbert Pardes & Constance E. Lieber, Philanthropy for Psychiatry, 163 AM.
J. PSYCHIATRY 766, 766–67 (2006) (“With reduced public funding and limited foundation
support, patient-inspired philanthropy serves as an invaluable alternative to cover much
of the deserted areas of social need,” including academic psychiatry. “[P]hilanthropy
should not be an area in which mental illness is given short shrift by provider and fundraising organizations”).
169. See, e.g., Elie Dolgin, Advocates to Bring Rare Disease Philanthropy Under One
Umbrella, 16 NATURE MED. 837, 837 (2010) (discussing rare disease philanthropy).
170. Cave et al., supra note 156, at 44, 47.
171. See, e.g., Ass’n of Healthcare Philanthropy Int’l Conference, With Health-Care Reforms, Hospitals Need Philanthropy More, FUND RAISING MGMT., Dec. 1993, at 47 (stating
that philanthropy is necessary due to the financial pressures brought about by health care
reform); Frequently Asked Questions, HUNTINGTON HOSP., http://www.huntingtonhospital.
com/Main/GivingFAQ.aspx (last visited Apr. 14, 2014) (“While Huntington Hospital has a
number of income sources, including insurance reimbursements and investment income,
the hospital is heavily dependent on private support from this community to maintain our
level of excellence.”).
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thropy is said to be one of the most vital and important sources of
revenue and financial support for health care institutions because
it is frequently unrestricted and can be used in any area of high
organizational or institutional need.172
Today, health care philanthropy is a big business supported by
attorneys,173 consultants,174 data connection organizations,175 and
professional associations.176 Services offered by health care philanthropy experts include grateful patient fundraising seminars,177 webinars,178 and workshops,179 as well as blog posts ad172. Rosalyn Stewart et al., Success in Grateful Patient Philanthropy: Insights from
Experienced Physicians, 124 AM. J. MED. 1180, 1184 (2011) (“Patient philanthropy can be
especially transformative because it is often unrestricted, thereby allowing for new and
creative ventures.”); Wright et al., supra note 64, at 649 (“Grateful patient philanthropy is
an essential part of keeping academic medical centers (AMC) moving forward . . . because
it is often unrestricted, and can allow for innovation in areas of high institutional need.”);
see also Zusman et al., supra note 140, at 178 (“For years, some neurosurgeons have eschewed philanthropy, but the profession must now view it as an important source of revenue.”).
173. Adam H. Greene & Kristen R. Blanchette, Time to Take Advantage of HIPAA Omnibus Rules “Good News”: Fundraising, Research, and Student Immunization Records,
DAVIS WRIGHT TREMAINE LLD (Apr. 2, 2013), http://www.dwt.com/Time-to-Take-Advan
tage-of-HIPAA-Omnibus-Rules-Good-News-Fundraising-Research-and-Student-Immuniza
tion-Records-04-02-2013/ (“The Omnibus Rule now also permits the use of department of
service, treating physician, outcome information, and health insurance status.”). Bob Belfort, a partner at Manatt, Phelps & Phillips, explains that many of his hospital clients
have an interest in targeting fundraising communications based on the nature of the
health care services received by the patient and the identity of the patient’s physician. See
HIPAA Final Rule Brings Changes to Marketing, Fundraising, HEALTHCARE FIN. NEW
(Mar. 11, 2013), http://www.healthcarefinancenews.com/news/hipaa-final-rule-brings-chan
ges-marketing-fundraising. Many of Belfort’s hospital clients also have physicians on their
medical staffs “make personal appeals to the patients.” Id. Belfort admits that, “I don’t
know whether patients will have a negative reaction to getting solicitations that indicate
fundraisers have looked at their data in more detail.” Id.
174. See, e.g., Healthcare, GRETZENBACH, GLIER & ASSOCIATES, http://www.grenze
bachglier.com/healthcare.html (last visited Apr. 14, 2014) (marketing themselves as
“[c]onsultants in [p]hilanthropic [m]anagement” and listing dozens of health care industry
clients including academic medical centers, hospitals, research institutes, and hospices,
among others); Foster Physician Engagement, THIRD SECTOR STRATEGY, http://www.third
sectorstrategy.com/physicians.html (last visited Apr. 14, 2014) [hereinafter Foster Physician Engagement] (“Third Sector Strategy provides training and resources to engage and
enable physicians to be vital partners for philanthropy.”).
175. See, e.g., Healthcare Funding Solutions, HARRIS CONNECT, http://www.bcharris
pub.com/images/HarrisConnectHealthcarefundraisingsolutions.pdf (last visited Apr. 14,
2014) (marketing itself as the “leader in grateful patient fundraising”).
176. See, e.g., Who We Are, ASS’N FOR HEALTHCARE PHILANTHROPY, http://sharepoint.
ahp.org/publicationandtools/News/mediakit/Documents/AHPFactSheet.pdf (last visited
Apr. 14, 2014) [hereinafter AHP, Who We Are] (advertising that “AHP is the leading authority for standards, knowledge, and leadership in health care philanthropy”).
177. See, e.g., AFP International Conference on Fundraising, ASS’N OF FUNDRAISING
PROF’LS, http://www.afpnet.org/Professional/content.cfm?ItemNumber=3097&navItemNu
mber=550 (last visited Apr. 14, 2014) (advertising various conferences with seminars host-
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dressing best practices in hospital fundraising generally and
grateful patient fundraising in particular.180 The Association for
Healthcare Philanthropy (“AHP”) is the largest professional organization dedicated exclusively to assisting charitable efforts in
health care organizations.181 AHP provides education and information to “chief development officers . . . major gift officers, annual campaign managers, event coordinators . . . grant writers,”
and other development personnel in all sectors of the health care
industry including health care systems, academic medical centers, general acute care hospitals, specialty hospitals, long-term
care facilities, hospices, institutionally related foundations, and
182
advocacy groups, among others. “AHP’s 5,000 members represent more than 2,200 health care facilities in the United States
183
and Canada.”
Understandably, AHP is very much in favor of HHS’s current
approach to fundraising. Following the January 25, 2013, release
of the Final Regulations, the President and Chief Executive Officer of AHP stated:
[T]he most positive element in the [Final Regulations] is that health
care providers and their institutionally-related foundations can obtain and use department of service information in order to focus appeals, communications and outreach to those donors and prospects
most likely to be interested in supporting the specific program related to that area of treatment. Reinstating this provision among the

ed by the Association of Fundraising Professionals).
178. See, e.g., Developing a Multichannel Grateful Patient Program to Identify Major
Donor Prospects, ASS’N OF FUNDRAISING PROF’LS, http://afp.peachnewmedia.com/store/sem
inar/seminar.php?seminar=14929 (last visited Apr. 14, 2014) (advertising a webinar for
purchase); Recording Information: Grateful Patient Fundraising Webinar, HARRIS
CONNECT, http://www.bcharrispub.com/patientfundraising?campaign=WODGP (last visited Apr. 14, 2014).
179. See, e.g., Foster Physician Engagement, supra note 174.
180. See, e.g., Tom Wilson, Best Practices in Grateful Patient Fundraising,
MAJORGIFTSGURU, http://majorgiftsguru.com/2009/05/best-practices-in-grateful-patient.ht
ml (last visited Apr. 14, 2014).
181. About Us, ASS’N FOR HEALTHCARE PHILANTHROPY, http://www.ahp.org/Home/
About_Us/Home/About_Us/About.aspx?hkey=5ed66e69-b202-401f-8aa1-3dfa14bdb488
(last visited Apr. 14, 2014) [hereinafter AHP, About Us]; AHP, Who We Are, supra note
176.
182. AHP, Who We Are, supra note 176.
183. AHP, About Us, supra note 181. Regional and state health care philanthropy associations also exist; see, e.g., NEW ENGLAND ASS’N FOR HEALTH CARE PHILANTHROPY, http://
www.neahp.org (last visited Apr. 14, 2014); OHIO ASS’N FOR HEALTHCARE PHILANTHROPY,
http://www.ohioahp.us (last visited Apr. 14, 2014).
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professionals in health care will assist in efficiency and growth for
184
health care philanthropy, which better serves communities.

Experts in health care philanthropy, including AHP, strongly
recommend grateful patient fundraising.185 Indeed, grateful patients are said to be the most importance source of financial donations to the health care industry.186 A grateful patient may be defined as a patient, or a family member of a patient, grateful for
the health care received by the patient and from whom an individual or institutional health care provider would like to solicit
funds.187 The simple theory behind grateful patient fundraising is
that patients who are grateful for the health care they have received may be more willing to make philanthropic contributions
compared to less satisfied patients and individuals who have no
relationship with the soliciting health care institution.188
Grateful patient fundraising can be conducted at two different
points in time: when the patient is in the hospital or other health
care institution as an inpatient or outpatient or after the patient
189
has been discharged or has returned home. During the first

184. Modifications to HIPAA Help Fundraisers Improve Efficiency, WEALTHENGINE
(Mar. 5, 2013), http://www.wealthengine.com/blog/2013/modifications-hipaa-help-fundrais
ers-improve-efficiency (internal quotation marks omitted).
185. Bullington, supra note 64, at 1; Dianna Dilworth, Past Patients an Untapped
Fundraising Source: Survey, DIRECT MARKETING NEWS (July 30, 2007), http://www.dm
news.com/past-patients-an-untapped-fundraising-source-survey/article/98021/.
186. See, e.g., Anthony N. DeMaria, Philanthropy and Medicine, 48 J. AM. C.
CARDIOLOGY 1725, 1725 (2006) (“Perhaps the greatest source of philanthropy is the grateful patient.”); Rum & Wright, supra note 65, at 55 (footnote omitted) (“In 2009, gifts from
individuals to academic health centers, health systems, and community hospitals in the
United States totaled $4.8 billion. A substantial proportion of this total—nearly $1 billion—came from grateful patients.”); Stewart et al., supra note 172, at 1180 (“Support
from grateful patients is the single most important source for substantive philanthropic
gifts in medicine.”).
187. See Bentz et al., supra note 138, at 2109.
188. See GRATEFUL PATIENTS, supra note 62, at 4 (“Anecdotal evidence indicates that
positive patient experiences lead to increased giving. While much study remains to be
done on the exact interaction between patient satisfaction, medical outcomes, and donor
behavior, medical environments . . . appear to support better philanthropic outcomes.”);
Grateful Patient Program, CLARK MEM’L HOSP., http://www.clarkmemorial.org/patientservices/grateful-patient-program/ (last visited Apr. 14, 2014) (“We’re often asked by patients who have such an experience if there’s a way they can express their gratitude and
appreciation for the care they or a family member received. That’s why we started the
Grateful Patients & Family Program. . . . Through our Grateful Patient & Family Program, you can express your appreciation for the special care you or your loved ones received through a special donation to the Clark Memorial Hospital Foundation.”).
189. See Bullington, supra note 64, at 3 (explaining that organizations can conduct daily patient visits and/or send fundraising communications through the mail after patient
discharge).
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time period, solicitations may be made in person during a private
conversation between a patient and an institutional representative or the patient’s physician. During the second time period, solicitations may be mailed, e-mailed, telephoned, or conducted in
person during a meeting or at a fundraising event.
According to health care philanthropy experts, timing is everything. Soliciting funds from a patient who is sick and lying in a
hospital bed or from a patient who has been waiting to see a physician for several hours is likely to be unsuccessful.190 Patients
have reported frustration with solicitations made very shortly after health care services are rendered, including one case where a
patient received a philanthropic solicitation two weeks after mak191
ing a single visit to a hospital for a mere physician consultation.
Fundraising experts further advise that philanthropic communications not be scheduled at the same time as hospital and other
health care bills are to be received by the patient.192 A majority of
first-time patient gifts are made within a year and a half of an
inpatient stay, however, waiting years after the patient has been
discharged home and all hospital bills have been paid is not rec193
ommended either.
IV. CONFIDENTIALITY ISSUES RAISED BY GRATEFUL PATIENT
FUNDRAISING
With this background regarding the benefits of health care philanthropy and the practice of grateful patient fundraising, this
article can now assess the confidentiality issues raised by grateful
patient fundraising. In the health care context, confidentiality
may be defined as the obligation of a health industry participant
to prevent the unauthorized or otherwise inappropriate use or
disclosure of voluntarily given and appropriately gathered health

190. See Lowman, supra note 64, at 10 (“Bad idea: Ask for a gift while a person is lying
in a hospital bed, has been sitting in your waiting area for 2 hours, etc.”).
191. See DeMaria, supra note 186, at 1725 (“[T]he concept that seeking medical care
may automatically trigger a request for a donation does seem to straddle the fine line between appropriate and unseemly.”).
192. See Bullington, supra note 64, at 4 (“Messaging and length of time between discharge and solicitation should be tested. You do not want your grateful patients to receive
their solicitation letters the same day they receive their bills. Working with the billing department can help alleviate overlap in this area.”).
193. See Lowman, supra note 64, at 10 (“But time is limited—the vast majority of firsttime patient gifts come within 18 months of an in-patient visit.)”.

TOVINO 484 (DO NOT DELETE)

2014]

4/18/2014 9:12 AM

HEALTH CARE PHILANTHROPY

1195

information relating to a patient.194 Grateful patient fundraising
raises confidentiality issues because patients voluntarily provide
health and other information about themselves to treating physicians and hospital support personnel in order to obtain a diagnosis and treatment. When a physician or other hospital representative uses or discloses that information for a purpose
unrelated to treatment, the question becomes whether the use or
disclosure is appropriate without prior patient notification and
permission. That is, has a physician or other hospital representative who used or disclosed a patient’s information for fundraising
violated the patient’s right to confidentiality?
As discussed in Part II of this article, the Privacy Rule now allows covered entities to use and disclose demographic information, insurance information, treating physician information,
department of service information, and health outcome information for fundraising purposes without patient authorization.195
As discussed in more detail below, this article argues that authorization should be sought and obtained before any information
other than demographic information and dates relating to the
provision of health care (collectively, “demographic information”)
is used or disclosed for fundraising purposes because: (1) patients
likely do not expect that their PHI is being used and disclosed for
fundraising purposes in exchange for their request for and receipt
of health care and HHS’s new Model Notice does nothing to improve patient expectations in this regard; (2) fundraising is neither a core function of covered entities nor necessary to support a
core function of covered entities; (3) a fundraiser who receives and
uses non-demographic information to create a targeted fundraising communication, or a third party who reads a targeted fundraising communication, could easily determine the patient’s general health condition or the health care services requested or
received by the patient; and (4) a close examination of the comments received by HHS in response to its 2010 Proposed Rule do
not indicate a shift in public attitudes regarding the appropriate
balance of confidentiality and philanthropy. Rather, the comments indicate that covered entities still would like to gather,
use, and disclose as much information as possible about patients

194. See Tovino, Functional Neuroimaging Information, supra note 11, at 441–42.
195. Privacy of Individually Identifiable Health Information, 45 C.F.R. § 164.514(f)(1)
(i)–(vi) (2013).
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for fundraising purposes and that patients’ rights advocates and
privacy coalitions still prefer to prioritize patient confidentiality.
The fact that covered entities would still like to gather, use, and
disclose an expanded class of PHI for fundraising does not mean
that philanthropy should, on a normative level, outweigh basic
patients’ rights. Rather, this article proposes that health information confidentiality and health care philanthropy be balanced
through a more express notification of fundraising and prior authorization requirement. Each of these four arguments will be
discussed in turn.
First, one test federal and state lawmakers have used to determine whether health care providers may use and disclose PHI
for a particular purpose without prior patient authorization is
whether a patient would reasonably expect that his or her PHI
would be used and disclosed for such purpose.196 For example,
HHS believes that most patients expect that when they present to
their primary care physician with a suspected broken arm, or to
their obstetrician with a suspected pregnancy, that the primary
care physician or obstetrician will share information with radiologists and laboratories as necessary to provide or confirm a diagnosis.197 For this reason, the Privacy Rule does not require the
196. See, e.g., Standards for Privacy of Individually Identifiable Health Information, 65
Fed. Reg. 82,462, 82,625 (Dec. 28, 2000) (to be codified at 45 C.F.R. pts. 160, 164) (stating
that in the context of patient expectations regarding the use and disclosure of PHI for biomedical and behavioral research: “A large number of commenters, however, indicated
that they did not expect that individually identifiable health information about themselves
would be used for research purposes without their authorization. Therefore, we retain
more stringent protections for research disclosures without patient authorization”);
Standards for Privacy of Individually Identifiable Health Information, 67 Fed. Reg.
14,776, 14,782–83 (proposed Mar. 27, 2002) (to be codified at 45 C.F.R. pts. 160, 164) (stating that in the context of whether one covered entity is permitted to disclose PHI to a second covered entity for the recipient entity’s health care operations: “The Department believes that this limitation is necessary in order to protect the privacy expectations of the
individual. An individual should expect that two providers that are providing treatment to
the individual, and the health plan that pays for the individual’s health care, would have
protected health information about the individual for health care operations purposes.
However, an individual would not expect a health plan with which the individual has no
relationship to be able to obtain identifiable information from his or her health care provider”); Texas Medical Records Privacy Act, TEX. HEALTH & SAFETY CODE § 181.005(c)(1)
(West 2012) (obligating the Executive Commissioner of the Texas Health and Human Services Commission, who is responsible for administering the Texas Medical Records Privacy
Act, to consider “the lives of individuals in th[e State of Texas] and their expectations of
privacy”).
197. See Standards for Privacy of Individually Identifiable Health Information, 64 Fed.
Reg. 59,918, 59,940 (proposed Nov. 3, 1999) (to be codified at 45 C.F.R. pts. 160–64) (“Our
proposal is intended to make the exchange of protected health information relatively easy
for health care purposes and more difficult for purposes other than health care. For indi-
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primary care physician or the obstetrician to obtain the patient’s
prior written authorization before disclosing information to the
radiologist or the laboratory.198 HHS also believes that most patients with health insurance expect (and perhaps hope) that their
health care providers will bill their insurers for health care services rendered so that the patients will not have to pay out of
pocket for their health care services. Again, the Privacy Rule does
not require a health care provider to obtain prior written authorization from a patient before disclosing the patient’s PHI to the insurer for payment or reimbursement purposes.199

viduals, health care treatment and payment are the core functions of the health care system. This is what they expect their health information will be used for when they seek
medical care.”); see also Standards for Privacy of Individually Identifiable Health Information, 67 Fed. Reg. 53,182, 53,208 (Aug. 14, 2002) (to be codified at 45 C.F.R. pts. 160,
164) (“In developing the Privacy Rule, the Department balanced the privacy implications
of uses and disclosures for treatment, payment, and health care operations and the need
for these core activities to continue. The Department considered the fact that many individuals expect that their health information will be used and disclosed as necessary to
treat them, bill for treatment, and, to some extent, operate the covered entity’s health care
business.”); Uses and Disclosures for Treatment, Payment, and Health Care Operations,
U.S. DEP’T HEALTH & HUMAN SERVS., http://www.hhs.gov/ocr/privacy/hippa/understand
ing/coveredentities/usesanddisclosuresfurtpo.html (last visited Apr. 14, 2014) (“Many individuals expect that their health information will be used and disclosed as necessary to
treat them, bill for treatment, and, to some extent, operate the covered entity’s health care
business. To avoid interfering with an individual’s access to quality health care or the efficient payment for such health care, the Privacy Rule permits a covered entity to use and
disclose protected health information, with certain limits and protections, for treatment,
payment, and health care operations activities.”).
198. Id.; see also Privacy of Individually Identifiable Health Information, 45 C.F.R. §
164.506(c)(1) (2013) (allowing covered entities to use and disclose PHI for treatment purposes without prior written authorization); Standards for Privacy of Individually Identifiable Health Information, 64 Fed. Reg. at 59,940 (“We therefore propose that covered entities be permitted to use and disclose protected health information without individual
authorization for treatment and payment purposes, and for related purposes that we have
defined as health care operations. For example, health care providers could maintain and
refer to a medical record, disclose information to other providers or persons as necessary
for consultation about diagnosis or treatment, and disclose information as part of referrals
to other providers. Health care providers also could use a patient’s protected health information for payment purposes such as submitting a claim to a payer. In addition, they
could use a patient’s protected health information for health care operations, such as use
for an internal quality oversight review.”).
199. See supra notes 197–98; see also 45 C.F.R. § 164.506(c)(1) (allowing covered entities to disclose PHI for payment purposes without prior written authorization); Standards
for Privacy of Individually Identifiable Health Information, 65 Fed. Reg. at 82,614 (“Activities we include in the definition of payment reflect core functions through which health
care and health insurance services are funded. It would not be appropriate for a rule about
health information privacy to hinder mechanisms by which health care is delivered and
financed. . . . Rather, we allow these activities to occur, subject to and consistent with the
requirements of this rule.”).
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The question becomes whether patients expect that their
health care providers will internally use their PHI and disclose
their PHI to development officers, major gifts officers, institutionally-related foundations, and BAs for fundraising purposes.
Although it would be helpful, research revealed no empirical research assessing patients’ expectations with respect to the use
and disclosure of their PHI for fundraising purposes. The question thus becomes whether we think that patients would expect
that their PHI will be used and disclosed for fundraising purposes
without their prior written authorization in exchange for their
request for and receipt of treatment.
I do not believe that patients expect that, as a result of requesting and receiving treatment at a hospital or other health care institution, their physicians and other hospital representatives will
use and disclose their PHI for fundraising purposes. That is, I do
not believe that patients have any idea that development officers
search demographic information to identify patients who live in
zip codes associated with expensive neighborhoods. I do not believe that patients know that major gift officers use cash payment
200
and Cadillac insurance status in an attempt to identify patients
who have the resources to make philanthropic donations. I do not
believe that patients know, or want, vice presidents of philanthropy at their hospitals’ institutionally related foundations—
folks who are very well known, well connected, and social in their
communities—to be accessing their treating physician’s name and
their department of service, which can suggest diagnosis or
health condition as well as the class of health care services requested or received. In summary, I believe that fundraising fails
the patient expectation test and that a more express prior notification and authorization requirement would serve the ethical
principle of respect for persons, including the obligation to provide information necessary for autonomous persons to make decisions about what happens to them and their health information.201

200. See generally Jenny Gold, ‘Cadillac’ Insurance Plans Explained, KAISER HEALTH
NEWS (Mar. 18, 2010), http://www.kaiserhealthnews.org/stories/2009/september/22/cadill
ac-health-explainer-npr.aspx (describing a “Cadillac” insurance plan as a relatively expensive plan that has excellent benefits and covers even the most expensive treatments).
201. See generally NAT’L COMM’N FOR THE PROT. OF HUMAN SUBJECTS OF BIOMEDICAL
& BEHAVIORAL RESEARCH, U.S. DEP’T HEALTH, EDUC. & WELFARE, ETHICAL PRINCIPLES
AND GUIDELINES FOR THE PROTECTION OF HUMAN SUBJECTS OF RESEARCH (Apr. 18, 1979)
[hereinafter BELMONT REPORT], available at http://www.hhs.gov/ohrp/humansubjects/guid
ance/belmont.html#erespect.
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My beliefs are supported by analogy to other positions HHS
has maintained regarding patient expectations. For example, as
discussed above, it is HHS’s view that patients do expect that
their PHI will be used and disclosed for treatment and insurance
reimbursement purposes, but that they do not expect that their
PHI will be used and disclosed for research purposes.202 Thus,
with a few exceptions, HHS generally requires authorization before a covered entity can use or disclose PHI for research purposes.203 I certainly agree with HHS’s decision to require authorization in the research context, and I also think that fundraising,
like research, is sufficiently unexpected not to allow waiver of patient authorization. My beliefs are also supported by the American Medical Association’s (“AMA”) Code of Medical Ethics and
many state health information confidentiality laws, which do not
contain exceptions to the general duty of confidentiality for fundraising and related data collection activities.204 Indeed, I associate

202. See supra note 197; Standards for Privacy of Individually Identifiable Health Information, 65 Fed. Reg. at 82,625 (“A large number of commenters, however, indicated
that they did not expect that individually identifiable health information about themselves
would be used for research purposes without their authorization. Therefore, we retain
more stringent protections for research disclosures without patient authorization.”).
203. See 45 C.F.R. § 164.512(i).
204. Privacy Policy, MARTIN & SUHEY ORTHOPEDICS, http://martinsuhey.com/privacypolicy-21 (last visited Apr. 14, 2014) (“In return for the patient’s honesty, the physician
generally should not reveal confidential communications or information without the patient’s express consent unless required to disclose the information by law. There are exceptions to the rule, such as where a patient threatens bodily harm to himself or herself or
to another person.”); Opinion 5.05-Confidentiality, in CODE OF MEDICAL ETHICS, AM. MED.
ASS’N, available at http://www.ama-assn.org/ama/pub/physician-resources/medical-ethics/
code-medical-ethics/opinion505. page? (last updated June 2007) (“The physician should not
reveal confidential information without the express consent of the patient, subject to certain exceptions which are ethically justified because of overriding considerations. When a
patient threatens to inflict serious physical harm to another person or to him or herself
and there is a reasonable probability that the patient may carry out the threat, the physician should take reasonable precautions for the protection of the intended victim, which
may include notification of law enforcement authorities. When the disclosure of confidential information is required by law or court order, physicians generally should notify the
patient. Physicians should disclose the minimal information required by law, advocate for
the protection of confidential information and, if appropriate, seek a change in the law.”);
Opinion 5.075-Confidentiality: Disclosure of Records to Data Collection Companies, in
CODE OF MEDICAL ETHICS, AM. MED. ASS’N available at http://www.ama-assn.org/ama/
pub/physician-resources/medical-ethics/code-medical-ethics/opinion5075.page? (last updated June 1998) (stating, with respect to the disclosure of confidential health information to
data collection companies: “Data collection from computerized or other patient records for
marketing purposes raises serious ethical concerns. . . . These arrangements may violate
principles of informed consent and patient confidentiality. Patients divulge information to
their physicians only for purposes of diagnosis and treatment. If other uses are to be made
of the information, patients must give their permission after being fully informed about
the purpose of such disclosures. If permission is not obtained, physicians violate patient
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biomedical and behavioral research more closely with treatment;
indeed, between research and fundraising, I would expect my PHI
to be used by my health care providers for research before it
would be used for fundraising.
In order to give patients notice of how they should expect their
PHI to be used and disclosed, the Privacy Rule does require patients to be given a document called a “notice of privacy practices.”205 The purpose of the notice of privacy practices is to give individuals “adequate notice of the uses and disclosures of protected
health information that may be made by the covered entity, and
of the individual’s rights and the covered entity’s legal duties
with respect to protected health information.”206 Covered entities
must give the notice of privacy practices to patients at their date
207
of first service delivery, post the notice in a clear and prominent
location where it is reasonable to expect individuals seeking services from the health care provider will be able to read the no208
tice, and make the notice available to any individual upon request,209 including when the notice is revised.210 The Privacy Rule
does not require patients to read or understand the notice, and it
does not require the covered entity to explain the notice to patients.211 The empirical literature assessing the use and readability of the notice of privacy practices suggests that many notices
are difficult to read and are written at a much higher reading

confidentiality by sharing specific and intimate information from patients’ records with
commercial interests. . . . Finally, these arrangements may harm the integrity of the patient-physician relationship. The trust that is fundamental to this relationship is based on
the principle that the physicians are the agents first and foremost of their patients.”),
available at http://www.ama-assn.org/ama/pub/physician-resources/medical-ethics/codemedical-ethics/opinion5075. page? (last visited Apr. 14, 2014); NEV. REV. STAT. §
449.720(2) (2012) (“Except as otherwise provided in NRS 108.640, 239.0115, 439.538,
442.300 to 442.330, inclusive, and 449.705 and chapter 629 of NRS [none of which relate to
fundraising], discussions of the care of a patient, consultation with other persons concerning the patient, examinations or treatments, and all communications and records concerning the patient are confidential.”).
205. See 45 C.F.R. § 164.520.
206. See id. § 164.520(a)(1).
207. Id. § 164.520(c)(2)(i)(A).
208. Id. § 164.520(c)(2)(iii)(B).
209. Id. § 164.520(c).
210. Id. § 164.520(c)(2)(iv).
211. See, e.g., Rachelle S. Stewart, Protective Measures for Private Health Information,
4 PERSP. HEALTH INFO. MGMT. 1, 5 (2007), available at http://www.ncbi.nlm.nih.gov/pmc/
articles/PMC2047293/pdf/phim0004-0005.pdf (“Some facilities simply ask patients to sign
the Privacy Practice form, but do not take the time to explain its provisions.”).
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level than plain language.212 In addition, the medical and privacy
literatures suggest that most patients do not even read HIPAArequired notices of privacy practices or other privacy policies.213
Assuming for the moment that a patient actually reads the notice of privacy practices either at the time of first service delivery
or in posted form, the required fundraising language can be short
and non-descriptive and may not actually describe the ambitious
nature of the fundraising activities undertaken by many covered
entities. Indeed, on September 16, 2013, HHS released its Model
Notice designed to comply with the Privacy Rule. The only fundraising language contained in the Model Notice provides: “In the
case of fundraising: We may contact you for fundraising efforts,
214
but you can tell us not to contact you again.” This concise
statement does nothing to inform patients (or raise patient expectations) regarding the classes of PHI that may be used without
prior patient authorization or the types of individuals and organizations, including employed major gifts officers, institutionallyrelated foundations, and contracted business associates, who may
receive PHI from covered entities for fundraising purposes.
A review of covered entities’ actual notices suggests that they
are not much better than HHS’s Model Notice. The Cleveland
Clinic Health System (“CCHS”) in Cleveland, Ohio, has a fourpage notice of privacy practices that states, in relevant part:
“Philanthropic Support. We may use general demographic information about you to contact you in an effort to raise funds to sup212. See, e.g., Anh T. Ha & Stuart A. Gansky, HIPAA Notice of Privacy Practices Used
in U.S. Dental Schools: Factors Related to Readability or Lack Thereof, 71 J. DENTAL
EDUC. 419, 424 (2007) (“Not surprisingly, most U.S. dental schools’ NPPs [notices of privacy practices] are quite difficult to read and at a much higher reading level than plain language.”); Steven Walfish & Keely M. Watkins, Readability Level of Health Insurance Portability and Accountability Act Notices of Privacy Practices Utilized by Academic Medical
Centers, 28 EVALUATION & HEALTH PROFS. 479, 479 (2005) (“The majority (65%) of [notices
analyzed] were written beyond the 12th-grade reading level, and almost the entire sample
(90%) fell in the difficult range of reading ease.”).
213. See, e.g., Memorandum from Paul M. Schwartz & Daniel Solove, Notice and
Choice: Implications for Digital Marketing to Youth, to The Second NPLAN/BSMG Meeting on Digital Media and Marketing to Children 2 (June 29-30, 2009), available at http://
changelabsolutions.org/sites/default/files/documents/Notice_and_choice.pdf (“An additional
major problem with notice and choice is that notice is illusory in practice. Privacy policies
are long, cumbersome, and hard to read. Moreover, most people do not read privacy policies.”); Observorship Program Guidelines and Evaluation Forms, AM. MED. ASS’N, available at http://www.ama-assn.org/ama/pub/about-ama/our-people/member-groups-sections/
interational-medical-graduates/observership-guidelines.page (last visited Apr. 14, 2014)
(“[M]ost patients do not read the Notice of Privacy Practices”).
214. MODEL NOTICE, supra note 5, at 4.
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port CCHS and its operations. We also will tell you how to cancel
these communications.”215 The language is so brief that even if noticed and read, it may not trigger any patient expectations regarding the philanthropic activities described in Part III of this
article. In addition, the language does not appear to have been
updated in light of the Final Regulations because there is no
mention of using or disclosing treating physician information, department of service information, or health outcome information.
Similarly, New York City’s Memorial Sloan-Kettering Cancer
Center (“Sloan-Kettering”) has an eight-page notice of privacy
practices. On page three, Sloan-Kettering states:
Fundraising. To support our business operations, we may use demographic and other information about you, including your name,
where you live or work, your health insurance status, your age and
gender, [and] the dates that you received treatment . . . in order to
contact you to raise money to help us operate. We may also share
this information with [a] . . . charitable foundation . . . who may con216
tact you to raise money on our behalf.

Slightly more descriptive than CCHS’s language, this language
may trigger some patient expectations regarding the philanthropic activities described in Part III of this article. However, the fact
that the fundraising paragraph is located on page three of an
eight-page notice certainly raises the question of whether the
language would be noticed and read. In addition, the notice does
not provide individuals with clear notice that they have the right
to opt out of fundraising activities.217 Like CCHS’s language,
Sloan-Kettering’s language also does not appear to have been updated in light of the Final Regulations because there is no mention of using or disclosing treating physician information, department of service information, or health outcome information.

215. Notice of Privacy Practices, CLEVELAND CLINIC HEALTH SYS., http://my.cleveland
clinic.org/Documents/Legal/npp.pdf (last visited Apr. 14, 2014).
216. Notice of Privacy Practices, MEMORIAL SLOAN-KETTERING CANCER CENTER (Sept.
23, 2013), available at http://www.mskcc.org/sites/files/node/2008/documents/revisedprivacy-practices-eng-201309v1.pdf.
217. If the general consent references fundraising activities and allows patients to opt
out of them, then the Privacy Rule’s requirements may technically be satisfied. Because
the general consent is not internally referenced, linked, or otherwise attached, however, I
am unable to determine whether the general consent references fundraising and the extent to which a patient can opt out of fundraising activities. Id.
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By final example, Sanford Health in Bismark, North Dakota,
has a nine-page notice of privacy practices. On page four, the notice states:
Fundraising communications[.] We may contact you to request a taxdeductible contribution to support important activities of [Sanford
Health]. In connection with any fundraising, we may disclose to our
fundraising staff demographic information about you (e.g., your
name, address and phone number) and dates on which we provided
218
healthcare to you.

Although Sanford Health’s language is very clear and concise, the
question, again, is whether patients will find the language on the
fourth page of the notice and, if so, whether the language will
trigger patient expectations regarding the philanthropic activities
described in Part III of this article. Since the language does not
appear to inform patients that they have the right to opt out of
receiving fundraising communications, the notice may technically
219
not comply with the Privacy Rule. Like CCHS’s and SloanKettering’s language, Sanford Health’s language also does not
appear to have been updated in light of the Final Regulations because it contains no mention of treating physician information,
department of service information, or health outcome information.
I do not believe that most patients expect that their PHI will be
used and disclosed for fundraising. Moreover, I do not believe that
the Privacy Rule’s notice of privacy practices requirement provides patients with such an expectation because: (1) many patients simply do not read notices of privacy practices; and, for
those patients who do read them; (2) the fundraising language in
HHS’s Model Notice and in covered entities’ actual notices is too
brief and insufficiently descriptive to trigger any expectations regarding the philanthropic activities described in Part III of this
article; (3) the fundraising language, even if descriptive, may be
located deep within a long notice and may not have been specifi-

218. About Sanford Health, SANFORD HEALTH, http://www.sanfordhealth.org/about
(last visited Apr. 14, 2014); What Is HIPAA?, SANFORD HEALTH, http://www.bis marck.
sanfordhealth.org/information/HIPAAbrochure.pdf (last visited Apr. 14, 2014). Sanford
Health merged with Medcenter One in 2012.
219. See Privacy of Individually Identifiable Health Information, 45 C.F.R. §
164.520(b)(1)(iii)(A) (2013) (stating that the notice of privacy practices must include “a
separate statement informing the individual . . . [i]n accordance with § 164.514(f)(1), the
covered entity may contact the individual to raise funds for the covered entity and the individual has a right to opt out of receiving such communications”).
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cally noticed; (4) some notices do not provide clear statements notifying patients that they have the right to opt out of receiving
fundraising communications; and (5) most covered entities do not
appear to have updated their notices of privacy practices in light
of the Final Regulations. For these reasons, I argue that the use
of the notice of privacy practices to trigger patient expectations
regarding fundraising and to provide notice of a patient’s right to
opt out of receiving fundraising communications is illusory in
practice.220
The second reason I believe fundraising activities that involve
PHI other than basic demographic information and dates of
health care should require prior patient authorization is that
fundraising is neither a core function of covered entities nor necessary to support the core functions of treatment and payment.
As background, the Privacy Rule permits covered entities to use
and disclose PHI without patient authorization when the purpose
of the use or disclosure is a core function of the covered entity or
an activity that is necessary to support a core function.221 The core
functions of covered entities include treatment and payment.222
That is, the main reason patients seek care from a health care
provider is for diagnosis and treatment.223 The core function of
health plans is to pay health care providers for the treatment
they have provided and to reimburse insured patients for health
care for which they have already paid.224 And, the core function of
health care clearinghouses is to transmit and translate information between and among health care providers, billing companies, and health care payers with the end goal of ensuring that
225
providers get paid for treating patients. Confidentiality gives
way to these important, core health care functions.

220. Schwartz & Solove, supra note at 213, at 1–2.
221. See Marketing, U.S. DEP’T HEALTH & HUMAN SERVS. (Apr. 3, 2003), http://
www.hhs.gov/ocr/privacy/hipaa/understanding/coveredentities/marketing.html [hereinafter HHS on Marketing] (distinguishing marketing activities from the core functions of
treatment and payment).
222. U.S. DEP’T HEALTH & HUMAN SERVS., PROTECTED HEALTH INFORMATION 16 (2003)
available at http://www.hhs.gov/ocr/privacy/hipaa/understanding/training/udmn.pdf (listing treatment and payment as core functions).
223. Id.
224. Id. at 15.
225. Id.; see also Privacy of Individually Identifiable Health Information, 45 C.F.R. §
160.103 (2013) (defining health care clearinghouse).
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The Privacy Rule does allow covered entities to use and disclose PHI without prior patient authorization for certain administrative, financial, and legal purposes that are necessary to support the core functions of treatment.226 For example, federal and
state laws require hospitals to assess the quality of health care
they provide,227 obtain a license to do business from the relevant
state agency,228 and obtain certification from the Centers for Medicare and Medicaid Services if they wish to obtain reimbursement
for providing health care services to Medicare and Medicaid beneficiaries.229 For these reasons, quality assurance, licensing, and
certification activities are considered necessary to support the
core functions of treatment and payment and prior patient au230
thorization is not required.
Even if they are helpful or beneficial or important, activities
that are not necessary to support the core functions of treatment
and payment do require prior patient authorization.231 For example, the act of selling patients’ PHI could be helpful to a covered
entity because it could generate income for the covered entity.
Because selling PHI is not necessary to treat patients or to support other core functions, the Privacy Rule generally prohibits
226. See PROTECTED HEALTH INFORMATION, supra note 222, at 39 (emphasis added).
227. See Conditions of Participation: Quality Assessment and Performance Improvement Program, 42 C.F.R. § 482.21 (2013) (noting that a federal Medicare condition requires participating hospitals to “develop, implement and maintain an effective, ongoing,
hospital-wide, data-driven quality assessment and performance improvement program”).
228. See, e.g., Illinois Hospital Licensing Act, 210 ILL. COMP. STAT. 85/4 (West 2008)
(“No person shall establish a hospital without first obtaining a permit from the Department [of Public Health].”).
229. See, e.g., Ctrs. for Medicare & Medicaid Servs., The Certification Process, in
STATE OPERATIONS MANUAL (1991), available at http://www.cms.gov/Regulations-andGuidance/Guidance/Manuals/Downloads/S0M107c02.pdf (providing information about how
health care providers and suppliers can become Medicare certified).
230. See PROTECTED HEALTH INFORMATION, supra note 222, at 16; Uses and Disclosures for Treatment, Payment, and Health Care Operations, U.S. DEP’T OF HEALTH &
HUMAN SERVS., at 2 (2003) available at http://www.hhs.gov/ocr/privacy/hipaa/understand
ing/coveredentities/usesanddisclosuresfortpo.html (explaining that “health care operations” include the “administrative, financial, legal, and quality improvement activities of a
covered entity that are necessary to run its business and to support the core functions of
treatment and payment,” and further explaining that health care operations include quality assurance, licensing, and certification); see also Standards for Privacy of Individually
Identifiable Health Information, 67 Fed. Reg. 53,182, 53,208 (Aug. 14, 2002) (to be codified
at 45 C.F.R. pts. 160, 164) (discussing core functions).
231. See HHS on Marketing, supra note 221, at 1 (“With limited exceptions, the Rule
requires an individual’s written authorization before a use or disclosure of his or her protected health information can be made for marketing. So as not to interfere with core
health care functions, the Rule distinguishes marketing communications from those communications about goods and services that are essential for quality health care.”).
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it.232 By further example, the act of marketing products and services to patients could be helpful to a covered entity because it
could generate additional income for the covered entity. Because
marketing is not necessary to treat patients or to support other
core functions, the Privacy Rule generally prohibits it without
prior patient authorization.233
In response to HHS’s 2010 Proposed Rule,234 several health care
providers submitted comments to HHS explaining that philanthropy is helpful, beneficial, and important. For example, Yale
University told HHS that “[i]t would be helpful if [HHS] were to
allow use of certain broad information, such as the name of the
clinical department or service that provided care, to assist cov235
ered entities in customizing their fundraising appeals.” Similarly, Indiana University explained to HHS that “[s]ome types of
covered entities, such as large, multi-disciplinary health care
providers or hospitals, may benefit from being able to use additional information to help identify appropriate recipients of fundraising communications.”236 Likewise, Beth Israel Deaconess Medical Center told HHS, “This is particularly important to large
academic medical centers like ours, and would allow us to use our
very limited resources to better target our fundraising efforts at
the Medical Center.”237 I agree with Yale, Indiana, and Beth Israel
that philanthropy is helpful, beneficial, and important; however, I
do not believe philanthropy is a necessary, core function of covered entities in the same way that treatment, payment, and
health care operations are.238

232. See Privacy of Individually Identifiable Health Information, 45 C.F.R. § 164.502
(a)(5)(ii)(A) (2013) (“[Except as permitted] . . . a covered entity or business associate may
not sell protected health information.”).
233. HHS on Marketing, supra note 221, at 1.
234. Modifications to the HIPAA Privacy, Security, and Enforcement Rules Under the
Health Information Technology for Economic and Clinical Health Act, 75 Fed. Reg. 40,868
(proposed July 14, 2010) (to be codified at 45 C.F.R. pts. 160, 164).
235. Letter from Dorothy K. Robinson, Vice President & Gen. Counsel, Yale Univ., to
Dep’t of Health & Human Servs., Office of Civil Rights 4 (Sept. 13, 2010) (on file with author) (emphasis added).
236. Letter from Marcia N. Gonzales, Exec. Dir. of Research Compliance, Indiana
Univ., to Dep’t of Health & Human Servs., Office of the Sec’y (Sept. 13, 2010) (on file with
author) (emphasis added).
237. Letter from Kristine C. Laping, Senior Vice President of Dev., Beth Israel Deaconess Med. Ctr., to Kathleen Sebelius, Sec’y, U.S. Dep’t of Health & Human Servs., Office for
Civil Rights (Sept. 13, 2010) (on file with author) (emphasis added).
238. But see Letter from David S. Guzick, Senior Vice President, Health Affairs, Univ.
of Fla., to Kathleen Sebelius, Sec’y, U.S. Dep’t of Health & Human Servs. Office for Civil
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The third reason I believe fundraising activities that involve
non-demographic PHI should require prior patient authorization
is that fundraisers who prepare and third parties who read targeted fundraising communications that reference patients’ treating physicians or departments of service could easily determine a
patient’s diagnosis or the type of health care services requested or
received. For example, a quick Internet search on my smart
phone revealed that New York City’s Dr. Nadege M. Coupet specializes in treating patients infected with the HIV virus,239 Las
Vegas’s Dr. Sheldon Freedman specializes in treating patients
with sexual dysfunction,240 and Phoenix’s Dr. Robert Cohen spe241
cializes in plastic surgery. A fundraiser who accesses the name
of a patient’s treating physician to prepare a targeted fundraising
communication as well as a third party who inadvertently reads
or receives the targeted communication could easily determine (in
the time it takes the fundraiser or third party to Google the name
of the physician on a smart phone) the patient’s general health
condition or the type of health care services requested or received
by the patient. Indeed, several individuals who commented on
HHS’s 1999 Proposed Rule stated that “disease or conditionspecific letters requesting contributions, if opened by the wrong
person, could reveal personal [health] information about the in242
tended recipient.”

Rights 4 (Sept. 13, 2010) (on file with author) (“Many [covered entities] are non-profits and
it is essential to their existence that they raise funds from the public . . . .”) (emphasis added); Letter from Susan Waltman, Exec. Vice President & Gen. Counsel, Greater N.Y.
Hosp. Assoc., to U.S. Dep’t of Health & Human Servs., Office for Civil Rights (Sept. 13,
2010) (on file with author) (“Fundraising efforts are crucial to a hospital’s ability to provide care and treatment to all patients.”) (emphasis added).
239. About Dr. Coupet, NADEGE M. COUPET, http://www.drcoupet.com/internal-med
icine-physician/ (last visited Apr. 14, 2014) (“I am a Board Certified African American
physician specializing in Internal Medicine and HIV Medicine.”); Health Services, NADEGE
COUPET, http://www.drcoupet.com/internist-doctor-health-services/hiv-sepcialist-nyc-hiv-in
fection (last visited Apr. 14, 2014) (“I am an AAHIVM certified HIV specialist with more
than 14 years experience in treating patients infected with the HIV virus.”).
240. Dr. Sheldon J. Freedman, SHELDON J. FREEDMAN, MD LTD., http://www.urology
channel.com/freedman/physicians.shtml (last visited Apr. 14, 2014) (“His medical practice
deals with urologic problems in men and women with special emphasis on sexual dysfunction, urologic oncology, pelvic floor reconstruction, stress incontinence, and stone disease.”).
241. Dr. Robert Cohen, DR. ROBERT COHEN, http://www.robertcohenmd.com/ (last visited Apr. 14, 2014) (describing Dr. Cohen as a board-certified plastic surgeon who practices
in Scottsdale, Arizona).
242. See Standards for Privacy of Individually Identifiable Health Information, 65 Fed.
Reg. 82,462, 82,718 (Dec. 28, 2000) (to be codified at 45 C.F.R. pts. 160, 164).
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In addition to the identity of the patient’s physician, the patient’s department of service also could reveal the patient’s health
condition or type of health care services requested or received by
the patient. For example, a patient who received services in a
hospital’s oncology department likely has cancer, had cancer, or
suspects that he or she has cancer. A patient who received services in a hospital’s chemical-dependency unit likely has a substance use disorder, is in recovery from a substance use disorder,
or suspects that he or she has a substance use disorder. A patient
who received services in a hospital’s behavioral health unit likely
has a mental illness, has a history of mental illness, or suspects
that he or she has a mental illness. With the exception of patients
who receive negative diagnostic test results, patients do not generally request or receive services from a particular department or
unit unless they require such services. In addition, patients who
suspect that they have certain illnesses, including mental illnesses, sexually transmitted diseases, and other sensitive conditions,
are as deserving of confidentiality as individuals who are diagnosed with such illnesses.
In summary, fundraisers who have access to the identity of the
patient’s treating physician and the patient’s department of service may be able to determine the patient’s diagnosis or type of
health care services requested or received. In addition, a targeted
fundraising letter sent to a patient’s home that is specific as to
the identity of the patient’s treating physician or department of
service can suggest the diagnosis of the patient or the type of
health care services requested or received to any third party who
intentionally or inadvertently happens to read or see the letter.
For these reasons, I argue that the patient’s prior written authorization should be obtained before a covered entity uses or discloses the name of the patient’s treating physician or the patient’s
department of service for fundraising purposes.243
The fourth reason I argue fundraising activities that use a patient’s non-demographic PHI should require prior authorization is
that a close examination of the comments received by HHS in response to its 2010 Proposed Rule do not indicate a shift in public
243. See AM. MED. ASS’N, COUNCIL ON ETHICAL AND JUDICIAL AFFAIRS, PHYSICIAN
PARTICIPATION IN SOLICITING CONTRIBUTIONS FROM PATIENTS CEJA REP. 7-A-04, at 3
(2004) (stating that a physician who sends “personalized solicitation letters to patients’
homes where others may notice them, or [a physician who communicates] patient information to third parties,” including fundraisers, may undermine confidentiality).
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attitudes regarding the proper balance of confidentiality and philanthropy. Rather, the comments indicate that covered entities
continue to want to gather, use, and disclose as much PHI as possible for fundraising purposes while patients’ rights advocates
and privacy coalitions continue to want to prioritize health information confidentiality. The fact that covered entities continue to
want to gather, use, and disclose expanded classes of PHI for
fundraising does not mean that philanthropy should, on a normative level, outweigh basic patients’ rights. Rather, as discussed in
more detail in Part V, I propose that health information confidentiality and health care philanthropy be balanced through a more
express notification of fundraising activities and a prior written
authorization requirement.
In response to its 2010 Proposed Rule, HHS received 306 comments totaling 2030 pages.244 Sixty-one of these comments contained the word “fundraising,”245 although not all of these sixtyone comments discussed the Privacy Rule’s fundraising requirements in detail. Fifty-five of these sixty-one comments were authored by health care providers, institutionally related foundations, other fundraising organizations, medical societies, health
plans, and health care attorneys, while six of these comments
were authored by patients’ rights advocates, privacy coalitions,
health information management organizations, and a professor
and his students in an ethics class at a graduate business
246
school.
In its 2010 Proposed Rule, HHS did not ask the public to carefully balance a patient’s right to confidentiality with a health care
provider’s desire to engage in grateful patient fundraising. The
only question HHS asked the public to consider was the narrow
question of whether the Privacy Rule’s fundraising provisions
should be loosened to allow covered entities to access a broader

244. Health Information Technology for Economic and Clinical Health Act: Modifications to the HIPAA Privacy, Security, and Enforcement Rules, REGULATIONS.GOV (Sept. 13,
2010), http://www.regulations.gov/#!docketDetail;D=HHS-OCR-2010-0016 (downloaded
individually and combined into one consecutively paginated document).
245. A search within the 306 comments for the word “fundraising” revealed sixty-four
comments. Id. Three of these comments, including those from the College of Healthcare
Information Management Executives, the California Hospital Association, and the World
Privacy Forum, appear to be duplicative, leaving sixty-one non-duplicative comments that
contain the word “fundraising.” See id.
246. Id.
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class of PHI, including a patient’s department of service, without
the patient’s prior authorization.247
The majority of the very small number of health care providers
and related organizations who responded supported the ability to
access treating physician, department of service, and health outcome information without prior patient authorization. The Greater New York Hospital Association (“GNYHA”), for example, supported HHS’s proposal to allow department of service information
to be used and disclosed without prior authorization.248 According
to GNYHA, “This approach would allow hospitals to narrow their
target audience, [and] provide a clear fundraising message . . . .”249
The Council for Advancement and Support of Education
(“CASE”), a leader in educational fundraising, also stated that access to additional categories of PHI would “strengthen grateful
patient fundraising and reduce costly and ineffective fundraising
communications.”250 CASE further explained that “[t]he current
restrictions limit the ability of college, university and foundation
fundraisers to effectively target their fundraising communications and provide patients a meaningful opportunity to support
251
their areas of care.”
Other health care providers also expressed their desire for access to treating physician and department of service information
without prior patient authorization. Providence Health & Services stated that “health care fundraising efforts could be
strengthened and streamlined with access to department of service or generic areas of treatment information.”252 The Johns
247. HHS specifically stated: “In particular, we solicit comment on: (1) Whether the
Privacy Rule should allow additional categories of protected health information to be used
or disclosed for fundraising, such as department of service or similar information, and if
so, what those categories should be.” Modifications to the HIPAA Privacy, Security, and
Enforcement Rules Under the Health Information Technology for Economic and Clinical
Health Act, 75 Fed. Reg. 40,868, 40,897 (proposed July 14, 2010) (to be codified at 45
C.F.R. pts. 160, 164).
248. Letter from Susan Waltman, Exec. Vice President & General Counsel, Greater
N.Y. Hosp. Ass’n, to U.S. Dep’t of Health & Human Servs., Office for Civil Rights 3 (Sept.
13, 2010) (on file with author).
249. Id.
250. Letter from John Lippincott, President, Council for Advancement & Support of
Education, to Office of the Sec’y, U.S. Dep’t of Health & Human Servs. 3 (Sept. 10, 2010)
(on file with author) .
251. Id. at 3–4.
252. Letter from John Koster, President & Chief Exec. Officer, Providence Health &
Servs., to U.S. Dep’t of Health & Human Servs., Office for Civil Rights 2 (Sept. 13, 2010)
(on file with author).
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Hopkins Health System agreed: “[I]n addition to the patient’s department of service, fund-raising efforts [should] be allowed to
use the name of the treating physician by the development office
or foundation without the necessity of an authorization.”253 The
Federation of American Hospitals shared Johns Hopkins’ view
that fundraising “is an important function, particularly for nonprofit institutions, and we believe that liberalization of the rules
in this area would not compromise the interests of individuals.”254
The problem is that these comments did not advance the real
question at hand of how to properly balance the need to protect
patient confidentiality with providers’ desire to use and disclose
PHI for philanthropic purposes. The bulk of the comments submitted simply reinforce the viewpoint of health care providers
and fundraisers that access to a larger subset of PHI could ease
their fundraising efforts.
It is not surprising that comments authored by patients’ rights
advocates and privacy coalitions expressed the opposing viewpoint. The World Privacy Forum firmly told HHS that “[s]haring
any health information with a fundraiser is a gross violation of
255
privacy.” The World Privacy Forum explained: “Telling a fundraiser that the patient was treated by a particular department
can be tantamount to disclosing the diagnosis. Sharing outcomes
256
information is just as bad.” Less upset, but still firm, was the
State of California Office of Health Information Integrity: “The
State of California is not in favor of allowing additional categories
of PHI to be used or disclosed for fundraising.”257

253. Letter from Donald L. Bradfield, Senior Counsel, the Johns Hopkins Health Sys.,
to U.S. Dep’t of Health & Human Servs., Office for Civil Rights 2 (Sept. 13, 2010) (on file
with author).
254. Letter from Fed’n of Am. Hosps., to the Honorable Kathleen Sebelius, Sec’y, U.S.
Dep’t of Health & Human Servs. 5 (Sept. 13, 2010) (on file with author).
255. Letter from Pam Dixon, Exec. Dir., World Privacy Forum, to the U.S. Dep’t of
Health & Human Servs., Office for Civil Rights 14 (Sept. 13, 2010) (on file with author)
(emphasis added).
256. Id. World Privacy Forum further stated: “Consider a person who had told no
friend or family of her cancer treatment who subsequently receives a call from a stranger
who knows about that treatment. How can any such use be justified under any circumstances? . . . Imagine that a hospital hired a business associate to do fundraising and that
you received a call from a neighbor, cousin, or colleague working for that fundraiser who
knew that you were treated by the oncology department?” Id.
257. STATE OF CAL., COMMENTS TO THE HIPAA PRIVACY, SECURITY & ENFORCEMENT
NPRM 14 (Sept. 13, 2010) (on file with author).
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The bipartisan Coalition for Patient Privacy agreed that confidentiality should trump philanthropy, and argued that patients
should have to affirmatively opt in to the receipt of fundraising
communications, citing the need to preserve the confidentiality of
sensitive health information.258 The Center for Democracy and
Technology (“CDT”) agreed with the Coalition for Patient Privacy;
that is, CDT wanted HHS to “[e]stablish an opt in standard for
fundraising communications to patients that use PHI beyond demographics and dates of service.”259
The College of Healthcare Information Management Executives similarly urged HHS to retain its current policy and “not attempt to enhance fundraising opportunities,” citing the operational difficulty of distinguishing between broad designations,
such as department of service, and narrow designations, such as
diagnosis, because the department of service (e.g., oncology) could
suggest the patient’s diagnosis (i.e., cancer).260
Finally, a professor and several of his students in an Ethics for
the Law Office Class at the Minnesota School of Business would
require prior patient authorization for fundraising. The class
stated, “We recognize the need for . . . funding for new medical
equipment and technology . . . but in achieving that goal, we
should not compromise private health information . . . .”261
Given that HHS only solicited public comment on the narrow
question of “[w]hether the Privacy Rule should allow additional
categories of protected health information to be used or disclosed
for fundraising, such as department of service or similar information,” the polarized comments referenced above are not sur262
prising. Health care providers want access to treating physician

258. Letter from Coal. for Patient Privacy, to the Honorable Kathleen Sebelius, Sec’y,
U.S. Dep’t of Health & Human Servs., Office of Civil Rights 18 (Sept. 13, 2010) (on file
with author).
259. Letter from Ctr. for Democracy & Tech. to Georgina Verdugo, Dir., Office for Civil
Rights, U.S. Dep’t of Health & Human Servs. 26 (Sept. 13, 2010) (on file with author).
260. Letter from Richard A. Correll, President & CEO, Coll. of Healthcare Info. Mgmt.
Execs., to Georgina Verdugo, Dir., Office for Civil Rights, U.S. Dep’t of Health & Human
Servs. 5 (Sept. 13, 2010) (on file with author).
261. Letter from Maria Greilinger, Tamara Daugherty, Marie Thorp, Roberta Kurth, &
Alan Witz, Ethics for the Law Office Class, Minnesota Sch. of Bus., to U.S. Dep’t of Health
& Human Servs., Office for Civil Rights 3 (on file with author).
262. Modifications to the HIPAA Privacy, Security, and Enforcement Rules Under the
Health Information Technology for Economic and Clinical Health Act, 75 Fed. Reg. 40,868,
40,897 (proposed July 14, 2010) (to be codified at 45 C.F.R. pts. 160, 164).
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and department of service information to ease their fundraising
efforts whereas patients’ rights advocates and privacy coalitions
do not want PHI, other than basic demographic information, to be
used or disclosed for fundraising. Each comment submitted reflected one of these two opposing positions. Perhaps if HHS had
asked for ideas regarding how to “better balance health information confidentiality with health care philanthropy,” or “how to
best preserve patient confidentiality while supporting health care
philanthropy,” the comments might have been more nuanced. Not
one health care provider who submitted a comment could even articulate one reason why philanthropy should trump confidentiality other than easing covered entities’ fundraising efforts. Not one
health care provider who submitted a comment seriously analyzed the confidentiality concerns raised by grateful patient fundraising and other health care philanthropy initiatives.
Again, HHS’s solicitation of comments on the narrow question
of whether access to additional PHI would make grateful patient
fundraising easier is partly to blame. Also blameworthy is administrative law’s notice-and-comment rulemaking process.263 Although a rich discussion of all of the problems associated with the
notice-and-comment rulemaking process is beyond the scope of
this article, a quick discussion of two illustrative problems might
help put the content of the Final Regulations in context.
First, although proposed rules are supposed to be vehicles for
policymaking, many policy decisions are made well before the relevant agency ever issues a proposed rule.264 Indeed, when HHS in
its 2010 Proposed Rule quietly solicited public comment on
whether to expand the classes of PHI that could be used and disclosed for fundraising without prior patient authorization,265 HHS
did not appear to be introducing a potential new policy the merits
of which could be considered by the public for the first time. Instead, HHS appeared to be adopting the September 2004 policy
recommendation of the National Committee on Vital and Health
Statistics (“NCVHS”) that a patient’s department of service could

263. The Regular Rulemaking Process, OFF. OF ADMIN. L., http://www.oal.ca.gov/regu
lar_Rulemaking_Process.htm (last visited April 14, 2014).
264. See Richard Murphy, Enhancing the Role of Public Interest Organizations in
Rulemaking via Pre-Notice Transparency, 47 WAKE FOREST L. REV. 681, 682 (2012).
265. See Modifications to the HIPPA Privacy, Security, and Enforcement Rules Under
the Health Information Technology for Economic and Clinical Health Act, 75 Fed. Reg. at
40,897.
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be used and disclosed for fundraising purposes without prior authorization.266 The NCVHS recommendations were based in part
on a July 2004 hearing where the NCVHS heard testimony from
representatives of AHP, an academic medical center, and a privacy institute.267 Not surprisingly, AHP and the academic medical
center were in favor of expanding the classes of PHI that could be
used and disclosed for fundraising purposes without prior patient
authorization whereas the privacy institute favored requiring
prior patient authorization.268 Without any attempt to balance
these two positions, the NCVHS (in a letter authored by its physician chair) simply decided to adopt the pro-philanthropy per269
spective articulated by AHP and the academic medical center.
Six years later, HHS in its 2010 Proposed Rule referenced the
NCVHS recommendations en route to proposing the loosening of
confidentiality in the context of health care philanthropy.270
In summary, the 2010 Proposed Rule should have been the initial vehicle for new policymaking relating to patient confidentiality in the context of fundraising. However, I suggest that HHS
made its policy decision back in 2004, after receiving the NCVHS
recommendations, and simply used the 2010 Proposed Rule (including the Rule’s very narrow request for comments) and the

266. Letter from John R. Lumpkin, Chairman, Nat’l Comm. on Vital & Health Statistics, to the Honorable Tommy G. Thompson, Sec’y, U.S. Dep’t of Health & Human Servs.
(Sept. 2, 2004), available at http://www.ncvhs.hhs.gov/020425lt.htm.
267. Id.
268. Id.
269. Id.
270. See Modifications to the HIPPA Privacy, Security, and Enforcement Rules Under
the Health Information Technology for Economic and Clinical Health Act, 75 Fed. Reg. at
40,897 (“NCVHS also held a hearing and heard public testimony on this issue in July
2004. After considering the testimony provided, the NCVHS recommended to the Secretary that the Privacy Rule should allow covered entities to use or disclose information related to the patient’s department of service (broad designations, such as surgery or oncology, but not narrower designations or information relating to diagnosis or treating
physician) for fundraising activities without patient authorization. NCVHS also recommended that a covered entity’s notice of privacy practices inform patients that their department of service information may be used in fundraising, and that patients should be
afforded the opportunity to opt out of the use of their department of service information for
fundraising or all fundraising contacts altogether. . . . In light of these concerns and the
prior recommendation of the NCVHS, the Department takes this opportunity to solicit
public comment on whether and how the current restriction on what information may be
used and disclosed should be modified to allow covered entities to more effectively target
fundraising and avoid inappropriate solicitations to individuals, as well as to reduce the
need to send solicitations to all patients.”).
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2013 Final Regulations to establish a formal administrative record should the Final Regulations become the subject of later judicial review.
A second problem with notice-and-comment rulemaking is that
its process can favor well-resourced industry participants. When
a particular regulatory action threatens the interests of an entire
industry, the participants in that industry can collectively invest
in attorneys, consultants, lobbyists, and politicians to protect
their interests. In the health care industry, heavily regulated
health care providers, health plans, and their professional associations frequently join forces to create professional, legal responses to proposed rules that can be signed and submitted by all of
the members of the industry or that can be copied and personalized by industry members and individually submitted. The result
is that HHS receives dozens of comments that support the same
position whenever it attempts to regulate the health care industry. In response to the 2010 Proposed Rule, for example, the AMA
joined forces with thirty-six other major medical societies, associations, and academies to submit a powerful, joint comment to
271
HHS. By further example, the AHP submitted its own thirteenpage, single-spaced comment to HHS272 that AHP’s members, including the Mary Bird Perkins Cancer Center and the Beth Israel
273
Deaconness Medical Center, then re-submitted and referenced,
respectively.
Notwithstanding the intellect and energy of patients’ rights
advocates and privacy coalitions such as the Coalition for Patient
Privacy274 and the World Privacy Forum,275 their legal, financial,
271. See Letter from Mari Savickis, Am. Med. Ass’n, to the Honorable Kathleen Sebelius, Sec’y, U.S. Dep’t of Health & Human Servs., Office for Civil Rights (Sept. 13, 2010),
available at http://wwwregulations.gov/#!documentDetail;D=HHS-OCR-2010-0016-0173.
272. See Letter from William C. McGinly, President & CEO, Ass’n for Healthcare Philanthropy, to Dep’t of Health & Human Servs., Office of the Sec’y (Sept. 13, 2010), available at http://www.regulations.gov/#!documentDetail;D=HHS-OCR-2010-0016-0137.
273. See Comment from Amy Benton, Mary Bird Perkins Cancer Ctr., to U.S. Dep’t of
Health & Human Servs. (Sept. 13, 2010), available at http://www.regulations.gov/#!docu
mentDetail;D=HHS-OCR-2010-0016-0122 (attaching the AHP’s comment and stating,
“Mary Bird Perkins Cancer Center and Mary Bird Perkins Cancer Center Foundation fully support the Association for Healthcare Philanthropy’s (AHP) position . . . . We have attached AHP’s comments”); see Letter from Kristine C. Laping, supra note 237, at 2 (“We
share the concerns expressed by the Association for Healthcare Philanthropy . . . .”).
274. Coalition for Patient Privacy, PATIENT PRIVACY RIGHTS, http://patientprivacy
rights.org/coalition-patient-privacy/ (last visited Apr. 14, 2014).
275. About Us, WORLD PRIVACY FORUM, http://www.worldprivacyforum.org/about-us.
html (last visited April 14, 2014).
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and other resources pale in comparison to the resources of the
likes of Yale University,276 Stanford University,277 and Beth Israel
Deaconess Medical Center,278 as well as the nation’s other outstanding academic medical centers and medical institutions. Patients’ rights advocates and privacy coalitions simply lack the resources to launch a comparable fight, including the resources to
submit high numbers of professional, persuasive comments.
One result is that agencies such as HHS usually receive more
comments from industry participants than from the nonregulated public. Again, in response to its 2010 Proposed Rule,
HHS received approximately fifty-five comments from the health
care industry that contained the word “fundraising.” In comparison, HHS received only six comments from patients’ rights organizations, privacy coalitions, health information management organizations, and an ethics class at a graduate business school. In
its Final Regulations, HHS explained that these numbers were
persuasive: “[T]he vast majority of commenters supported allowing the use or disclosure of additional protected health information for fundraising” and “a small minority of commenters opposed allowing the use of additional protected health information
to target fundraising efforts, citing privacy concerns with doing
so.”279 Given that the notice-and-comment rulemaking process can
favor industry, I argue that simply counting the (relatively small
number of) comments submitted on behalf of the nation’s hundreds of thousands of health care providers that make up the $2.7
trillion health care industry280 and comparing that number to the
number of comments submitted by patients’ rights and privacy
coalitions is not a reason to favor philanthropy over confidentiali276. See Letter from Dorothy K. Robinson, supra note 235.
277. See Letter from Privacy Officer, Dir. of Research Compliance, & Privacy & Sec.
Officers, Stanford Univ., to U.S. Dep’t of Health & Human Servs., Office for Civil Rights
(Sept. 13, 2010), available at http://www.regulations/gov/#!documentDetail;D=HHS-OCR2010-0016-0263.
278. See Letter from Kristine C. Laping, supra note 237, at 1.
279. Modifications to the HIPAA Privacy, Security, Enforcement, and Breach Notification Rules under the Health Information Technology for Economic and Clinical Health Act
and the Genetic Information Nondiscrimination Act, 78 Fed. Reg. 5566, 5620 (Jan. 25,
2013) (to be codified at 45 C.F.R. pts. 160, 164). According to HHS, “These commenters
stated that the use of additional protected health information would streamline their
fundraising efforts and ensure that individuals were sent communications about campaigns that would be meaningful to their experiences.” Id.
280. Elisabeth Rosenthal, The $2.7 Trillion Medical Bill: Colonoscopies Explain Why
U.S. Leads the World in Health Expenditures, N.Y. TIMES, June 2, 2013, at A1 (referencing
the nation’s $2.7 trillion annual health care bill).
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ty. Instead, I suggest that the notice-and-comment rulemaking
process favors well-resourced industry participants.281 To me, the
comments simply indicate that covered entities continue to want
to gather, use, and disclose PHI about patients for fundraising
purposes while patients’ rights advocates and privacy coalitions
continue to want to prioritize confidentiality. The fact that covered entities continue to want to gather, use, and disclose PHI for
fundraising does not mean that philanthropy should, on a normative level, outweigh basic patients’ rights. Rather, and as discussed in more detail in the final Part of this article, I propose
that health information confidentiality and health care philanthropy be balanced through a more express notification of fundraising and authorization requirement.
V. A PROPOSAL
In this final Part, I examine three options for the future regulation of the use and disclosure of PHI for fundraising and select
the option that I believe creates the best balance between health
care philanthropy and health information confidentiality.
One option is to revise the Final Regulations to prohibit all
grateful patient fundraising. If grateful patient fundraising risks
breach of confidentiality (and a range of other ethical issues including conflicted decision making, health care resource alloca282
tion injustices, financial exploitation, and breach of privacy),
then one approach is to eliminate grateful patient fundraising in
its entirety. This option could be implemented by deleting the
language currently codified at 45 C.F.R. § 164.514(f)(1)–(2) or by
deleting such language and replacing it with:
(f) Fundraising communications. A covered entity may not use, or
disclose to a business associate or to an institutionally related foundation, any protected health information for fundraising or philanthropic purposes.

I disagree with this approach. As discussed in detail in Part III,
philanthropy supports a wide variety of important health care initiatives and related educational missions. Academic medical cen281. See Murphy, supra note 264, at 683 (“Thus, it is possible that changes made to the
rulemaking process that were intended, in part, to enable strong public interest group participation may often disfavor such groups.”).
282. See generally Tovino, Giving Thanks, supra note 9 (discussing the ethical issues
raised by physician involvement in grateful patient fundraising).
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ters rely on philanthropy to satisfy educational needs, research
programs, clinical initiatives, and building and infrastructure
support. Non-profit health care organizations engage in fundraising to provide resources to their community-based hospitals and
clinics and to improve access to health care and other services for
the uninsured and under-insured. Private health care foundations use philanthropy to serve the economically poor and underserved, including women, children, and seniors who live in the
community served by the foundation. Health care philanthropy,
which totaled $28.12 billion in 2012,283 cannot be eliminated in its
entirety.
A second option is to maintain the status quo. That is, a second
option is to: (1) keep the language in the Final Regulations allowing covered entities to use and disclose treating physician and
department of service information without prior patient authorization; and (2) support our current approach to health care philanthropy which relies on significant physician involvement in
grateful patient fundraising. As discussed in significant detail
elsewhere, I dislike this option because it provides insufficient
protection of the physician-patient relationship and risks conflicted decision making, health care resource allocation injustices, financial exploitation, breach of privacy, and breach of confidential284
ity.
A third option is to allow grateful patient fundraising to proceed with some limitations that are designed to protect health information confidentiality and other basic patients’ rights. This option, which I support, would require: (1) the revision of the Final
Regulations to better protect health information confidentiality;
and (2) the adoption of a complementary set of ethical guidelines
governing physician involvement in grateful patient fundrais285
ing.
In terms of revising the Final Regulations, I first propose that
covered entities not be allowed to use or disclose treating physician and department of service information without prior patient
authorization. Thus, I propose that 45 C.F.R. § 164.514(f)(1) be
revised to read:
283. Charitable Giving Rose 3.5 Percent in 2012, GIVING USA (June 20, 2013), http://
www.givingusareports.org/news-and-events/news.aspx?NewsTypeId=3& NewsId=182.
284. See generally Tovino, Giving Thanks, supra note 9.
285. See id. (adopting a complementary set of ethical guidelines).
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(f) Fundraising communications. (1) Standard: Uses and disclosures
for fundraising. Subject to the conditions of paragraph (f)(2) of this
section, a covered entity may use, or disclose to a business associate
or to an institutionally related foundation, the following protected
health information for the purpose of raising funds for its own benefit, without an authorization as defined in paragraph (f)(3):
(i) Demographic information relating to an individual, including name, address, other contact information, age, gender, and
date of birth;
(ii) Dates of health care provided to an individual; and
(iii) Health insurance status.

Second, and in conjunction with the ethical proposals made in
the companion article, I propose that 45 C.F.R. § 164.514(f)(2)(i)
be revised to require patients be notified regarding whether the
covered entity will be conducting wealth screenings and other information searches using publicly or commercially available information:
(f)(2) Implementation specifications: Fundraising requirements.
(i) A covered entity may not use or disclose protected health information for fundraising purposes as otherwise permitted by
paragraph (f)(1) of this section unless: (a) a statement required
by 164.520(b)(1)(iii)(A) is included in the covered entity’s notice
of privacy practices; and (b) a statement indicating whether
the covered entity will conduct patient wealth screenings and
other information searches using publicly or commercially
available information is included in the covered entity’s notice
of privacy practices.

In turn, 45 C.F.R. § 164.520(b)(1)(iii)(A), which describes the
way in which patients should be alerted to uses and disclosures of
their PHI for fundraising through the notice of privacy practices,
should be amended to provide:
(b)(1)(iii) Separate statements for certain uses or disclosures. If the
covered entity intends to engage in any of the following activities,
the description required by paragraph (b)(1)(ii)(A) of this section
must include a separate statement informing the individual of such
activities, as applicable:
(A) In accordance with § 164.514(f)(1), the covered entity may,
without prior written authorization, use and disclose to institutionally-related foundations and associates the information
listed at paragraph (f)(1)(i)–(iii), as long as the covered entity
provides information regarding how the individual may opt out
of these information uses and disclosures. In accordance with §
164.514(f)(3), the covered entity may, but only with prior written authorization, use and disclose to institutionally-related
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foundations and business associates protected health information other than the information listed at paragraph (f)(1)(i),
together with information regarding how the individual may
authorize such uses and disclosures.

Third, I propose adding a new 45 C.F.R. § 164.514(f)(3) to the
end of the fundraising regulation. This new subsection would establish standard fundraising notification and authorization language that covered entities would use to notify patients regarding
their philanthropy activities and obtain their patients’ prior written authorization. The new subsection would provide:
(f)(3) Fundraising notification and authorization. A covered entity
may use or disclose protected health information in addition to the
information listed at paragraph (f)(1)(i)–(iii) for fundraising purposes
only if the covered entity provides express written notification to the
patient regarding the means the covered entity uses to obtain philanthropic donations and obtains the individual’s prior written authorization to such means. A valid fundraising notification and authorization must include at least the following elements:
(A) The name and address of the covered entity;
(B) A statement that the covered entity uses patient fundraising to support clinical initiatives, educational missions, or other health care or educational goals, as appropriate;
(C) A description of the means the covered entity uses to obtain
philanthropic donations, including a description of any physician involvement in grateful patient fundraising, development
office involvement in grateful patient fundraising, institutionally-affiliated foundation involvement in fundraising, independent contractor or business associate involvement in fundraising, the conduct of wealth screenings, and similar
measures;
(D) A description of the specific classes of protected health information, such as treating physician and department of service information, that the patient is authorizing the covered
entity to use and disclose for fundraising purposes;
(E) The name(s) of any employed, affiliated, or contracted
fundraisers with whom these classes of protected health information will be shared or to whom these classes of protected
health information will be disclosed;
(F) A statement that employed, affiliated, and contracted fundraisers may not further use or disclose protected health information other than for fundraising purposes;
(G) A statement that employed, affiliated, and contracted fundraisers are subject to regulation by the federal HIPAA Privacy
Rule and are subject to civil and criminal penalties for unauthorized uses and disclosures of protected health information;
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(H) A statement that the covered entity’s primary relationship
with the patient is a treatment relationship, not a philanthropic relationship;
(I) A general statement that the covered entity may not condition treatment, payment, or health care operations on a fundraising authorization or philanthropic donation;
(J) A specific statement that the covered entity may not vary
the provision, timing, quality, or quantity of treatment on a
fundraising authorization or philanthropic donation;
(K) A statement regarding how the individual may contact the
covered entity’s Privacy Official to discuss concerns regarding
fundraising. This statement shall include the postal address,
telephone number, and email address of the covered entity’s
Privacy Official;
(L) A statement regarding how the individual may contact the
federal Department of Health and Human Services (“HHS”) to
complain and report a breach of confidentiality by either the
covered entity or a contracted fundraiser. This statement shall
include a link to HHS’s “How to File a Complaint” Web page,
available at http://www.hhs.gov/ocr/privacy/hipaa/complaints/;
and
(M) Signature of the individual and date. If the authorization
is signed by a personal representative of the individual, a description of such representative’s authority to act for the individual must also be provided.

Fourth, I propose that HHS revise its Model Notice, which currently contains the following superficial statement: “In the case of
fundraising: We may contact you for fundraising efforts, but you
286
can tell us not to contact you again.” The Model Notice should
be revised to provide:
In the case of fundraising:
Without your prior written authorization, we may internally
use and disclose to institutionally-related foundations and
business associates certain demographic information (including name, address, other contact information, age, gender, and
date of birth), dates of health care provided to you, and information regarding your health insurance status. You may opt
out of these unauthorized information uses and disclosures by
contacting the Privacy Official at the following [email address],
[physical mailing address], or [telephone number].
Only with your prior written authorization, we may internally use and disclose to institutionally-related foundations and
business associates protected health information other than
demographic information, dates of health care, and health in-

286.

MODEL NOTICE, supra note 5, at 4.
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surance status. You may authorize such uses and disclosures
by contacting the [Name of Covered Entity] Privacy Official at
the following [email address], [physical mailing address], or
[telephone number].

CONCLUSION
Philanthropy plays an important role in the American health
care system. Due to high uncompensated health care costs, inadequate Medicare and Medicaid reimbursement, rising health care
compliance costs associated with health care reform, and expensive medical equipment, many health care institutions depend on
philanthropic donations. For these reasons, health care philanthropy should be encouraged.
One concern with health care philanthropy is its reliance on
the use and disclosure of patient identifiable information and the
associated risk of breach of confidentiality. This concern can be
lessened through the proper regulation of the use and disclosure
of protected health information for fundraising. To this end, this
article critiques and proposes corrections to Privacy Rule and
Model Notice provisions that govern the permissible scope of uses
and disclosures of protected health information for fundraising
purposes. These regulatory proposals are designed to support
health care philanthropy while protecting a patient’s right to
health information confidentiality.

